Discover top B2B leads for Biotechnology industry
Identify and research relevant prospects for B2B lead generation on Biotechnology sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for businesses based on their specifics like location, name or category.
AbbVie
AbbVie is a pharmaceutical company that discovers,Show more... develops, and markets medicines.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
338 Emails
0 Phones
Main email format: sarah.smith@abbvie.com (47.2%)
-
Melanie Cohen
m***********n@abbvie.com
-
Nancy Vangeys
n***********s@abbvie.com
-
Andrew Dillard
a************d@abbvie.com
-
Jennifer Langan
j*************n@abbvie.com
-
Jay Stamatis
j**********s@abbvie.com
-
Miki Mancine
m**********e@abbvie.com
-
Catherine Desjardins
Regional Manager, Market Access and Government Affairs in Oncology
c******************s@abbvie.com
-
Felix J Gonzalezreyes
f*****************s@abbvie.com
-
Ateet Shah
a********h@abbvie.com
-
Robert Michael
President and Chief Operating Officer
r****t@abbvie.com
-
Tim Hale
t******e@abbvie.com
-
Kumar Kantheti
Head of Customer Insights at Regeneron Pharmaceuticals, Inc.
k************i@abbvie.com
-
Alfonso Savoia
a************a@abbvie.com
-
Marie-Charlotte GOFF
m*******************f@abbvie.com
-
Carrie Strom
Senior Vice President, US Medical Aesthetics
c**********m@abbvie.com
-
Glen Curran
Vice President, Marketing, US Eyecare
g*********n@abbvie.com
-
Jessica Campagna
Director, Regulatory Affairs
j**************a@abbvie.com
-
Natalie Anderten
Director, Clinical Development Operations
n**************n@abbvie.com
-
Gamal Ferrer
Supply Planning Manager
g**********r@abbvie.com
-
Alex Selsky
a*********y@abbvie.com
-
Bill Pappano
b**********o@abbvie.com
-
Laurence Pierard
l**************d@abbvie.com
-
Jane Woo
j******o@abbvie.com
-
Liz Lloyd
l*******d@abbvie.com
-
Francescaeugenia Civardi
f**********************i@abbvie.com
-
Eric Nelson
e*********n@abbvie.com
-
Hanne Vanspaendonk
h****************k@abbvie.com
-
Jacob Degner
j**********r@abbvie.com
-
Nestor Ortiz
n**********z@abbvie.com
-
Philip Mcquain
p************n@abbvie.com
-
Tamar Uziel
t*********l@abbvie.com
-
Jill Hoeger
j*********r@abbvie.com
-
Ahmed Othman
a**********n@abbvie.com
-
Earle Bain
e********n@abbvie.com
-
Lisa Greenstein
l*************n@abbvie.com
-
Samrat Mukherjee
s**************e@abbvie.com
-
Lloyd Lam
l*******m@abbvie.com
-
Joshua Plotnik
j************k@abbvie.com
-
Stephen Fortino
s*************o@abbvie.com
-
Robert A Love
r***********e@abbvie.com
-
Tino Seidel
t*********l@abbvie.com
-
John Engelhardt
j*************t@abbvie.com
-
Mk Steel
m******l@abbvie.com
-
Carlos Taveras
c************s@abbvie.com
-
Jens Herrfurth
j************h@abbvie.com
-
Carola Vogt
c*********t@abbvie.com
-
Ariel Ting
a********g@abbvie.com
-
Anja Moeller
a**********r@abbvie.com
-
Scott Filarski
s************i@abbvie.com
-
Joachim Vogt
j**********t@abbvie.com
-
Josue Samayoa
j***********a@abbvie.com
-
Krystal Loewe
k***********e@abbvie.com
-
Jan Lohne
j*******e@abbvie.com
-
Bei Chen
b******n@abbvie.com
-
Francesca Marrani
f***************i@abbvie.com
-
Silvija Vaitkiene
s***************e@abbvie.com
-
Thorsten Pflanzner
t****************r@abbvie.com
-
Sara Orndoff
s**********f@abbvie.com
-
Antonis Papasolomontos
a********************s@abbvie.com
-
Philipp Huwe
p**********e@abbvie.com
-
Krystal Bruno
k***********o@abbvie.com
-
Lisa Miller
l*********r@abbvie.com
-
Erica Gruvberg
e************g@abbvie.com
-
Lavina Harjani
l************i@abbvie.com
-
Andrew D Vogt
a***********t@abbvie.com
-
Meri Oliva
m********a@abbvie.com
-
Mariadelcarmen Estrada
m********************a@abbvie.com
-
Elena Dianova
e***********a@abbvie.com
-
Dawn George
d*********e@abbvie.com
-
Kent Pearson
k**********n@abbvie.com
-
Kei Takatsu
k*********u@abbvie.com
-
Johannes Huelsenbeck
j******************k@abbvie.com
-
Shunya Urata
s**********a@abbvie.com
-
Sebastian Koob
s************b@abbvie.com
-
Paul E Kroeger
p************r@abbvie.com
-
Be Mnp
b****p@abbvie.com
-
Christopher Kwok
c**************k@abbvie.com
-
Brendan Mccarthysinclair
b**********************r@abbvie.com
-
Margaret Fettiskoenders
m*********************s@abbvie.com
-
Pv Saudiarabia
p************a@abbvie.com
-
Carleigh Kmetz
c************z@abbvie.com
-
Ed Reilly
e*******y@abbvie.com
-
Cyril Ramathal
c************l@abbvie.com
-
Xin X Lu
x******u@abbvie.com
-
Adrian Hobson
a***********n@abbvie.com
-
Jason Holbert
j***********t@abbvie.com
-
Susan Bale
s********e@abbvie.com
-
Cynthia Waseity
c*************y@abbvie.com
-
Michal Roszkowski
m***************i@abbvie.com
-
Mike Dennis
m*********s@abbvie.com
-
Robert Grundman
r*************n@abbvie.com
-
Sebastian Wachtarz
s****************z@abbvie.com
-
Michael R Robinson
m****************n@abbvie.com
-
Mansour Dughbaj
m*************j@abbvie.com
-
Yixin Fang
y********g@abbvie.com
-
Lisa Hazelwood
l************d@abbvie.com
-
Hannah Palac
h**********c@abbvie.com
-
Yu Deng
y*****g@abbvie.com
-
Elizabeth Shea
e************a@abbvie.com
-
Sarah Beck
s********k@abbvie.com
-
Natalie Bennett
n*************t@abbvie.com
-
Cheryl Pitcher
c************r@abbvie.com
-
Joanna Jones
j**********s@abbvie.com
-
Nancy Sever
n*********r@abbvie.com
-
Kim Hogan
k*******n@abbvie.com
-
David Maag
d********g@abbvie.com
-
Hetal Sarvaiya
h************a@abbvie.com
-
Yuki Koshi
y********i@abbvie.com
-
Stevan W Djuric
s*************c@abbvie.com
-
Hiroki Matsuo
h***********o@abbvie.com
-
Martha Titler
m***********r@abbvie.com
-
Alexandra Smith
a*************h@abbvie.com
-
Lauren Himmel
l***********l@abbvie.com
-
Forrest Weghorst
f**************t@abbvie.com
-
Nakesha Spellman
n**************n@abbvie.com
-
Parul Singh
p*********h@abbvie.com
-
Isheeta Shah
i**********h@abbvie.com
-
Christian Sanandres
c*****************s@abbvie.com
-
Anil Vasudevan
a************n@abbvie.com
-
Justin Rayyan
j***********n@abbvie.com
-
James Marek
j*********k@abbvie.com
-
Sophee Blanthornhazell
s********************l@abbvie.com
-
Rahul Mehta
r*********a@abbvie.com
-
Javier Leaniz
j***********z@abbvie.com
-
Jit Bhowmick
j**********k@abbvie.com
-
David Masica
d**********a@abbvie.com
-
Robert Mclaughlin
r***************n@abbvie.com
-
Anuj Verma
a********a@abbvie.com
-
Jianzhen Chan
j***********n@abbvie.com
-
Stephanie Weinstein
s*****************n@abbvie.com
-
Brian C Anderson
b**************n@abbvie.com
-
Karol Charkiewicz
k***************z@abbvie.com
-
Shawn Jeffries
s************s@abbvie.com
-
Stacy Sullivan
s************n@abbvie.com
-
Geoff Gz Zhang
g************g@abbvie.com
-
Namita Tundia
n***********a@abbvie.com
-
Sarah Doupe
s*********e@abbvie.com
-
Chris Medina
c**********a@abbvie.com
-
Takafumi Tanaka
t*************a@abbvie.com
-
Razaq Salau
r*********u@abbvie.com
-
Chelsea Parrocha
c**************a@abbvie.com
-
Jane Qian
j*******n@abbvie.com
-
Bryan Rogers
b**********s@abbvie.com
-
Michael Kaltschmidt
m*****************t@abbvie.com
-
Jeroen Schrevens
j**************s@abbvie.com
-
Jamie Chouinard
j*************d@abbvie.com
-
Jeffrey Waite
j***********e@abbvie.com
-
Jason Hart
j********t@abbvie.com
-
Jules Holland
j***********d@abbvie.com
-
Melvin Munsaka
m************a@abbvie.com
-
Namjin Chung
n**********g@abbvie.com
-
Ning Sun
n******n@abbvie.com
-
Edward Ronan
e**********n@abbvie.com
-
Niharika Chauhan
n**************n@abbvie.com
-
Lin Zhu
l*****u@abbvie.com
-
Anna Levi
a*******i@abbvie.com
-
Giuliana Gualberti
g****************i@abbvie.com
-
Naoki Wasa
n********a@abbvie.com
-
Zoltan Dezso
z**********o@abbvie.com
-
Reyhaneh Nazarian
r***************n@abbvie.com
-
Nam Bui
n*****i@abbvie.com
-
Dalila Miele
d**********e@abbvie.com
-
Keturah Kiper
k***********r@abbvie.com
-
Andrella King
a***********g@abbvie.com
-
Sana Khajehpour
s*************r@abbvie.com
-
Rebecca Kattan
r************n@abbvie.com
-
Jerry Jacob
j*********b@abbvie.com
-
Heather Huang
h***********g@abbvie.com
-
Catherine Ho
c**********o@abbvie.com
-
Melanie Flores
m************s@abbvie.com
-
Payal Bhatt
p*********t@abbvie.com
-
Laura Gasparini
l*************i@abbvie.com
-
Kartik Anne
k*********e@abbvie.com
-
Minna Abdelaziz
m*************z@abbvie.com
-
Josette Hughes
j************s@abbvie.com
-
Megan Jimerson
m************n@abbvie.com
-
Teresa K Oberlander
t*****************r@abbvie.com
-
Roland Heym
r*********m@abbvie.com
-
Aoi Kurano
a********o@abbvie.com
-
Jeff Onyskiw
j**********w@abbvie.com
-
Jodi Walker
j*********r@abbvie.com
-
Evgenyi Shalaev
e*************v@abbvie.com
-
Yunzhao Xing
y**********g@abbvie.com
-
Aparna Shinde
a***********e@abbvie.com
-
Leonie Hammer
l***********r@abbvie.com
-
Gregory Willocq
g*************q@abbvie.com
-
Bobbi Wiggins
b***********s@abbvie.com
-
Yoosook Kim
y*********m@abbvie.com
-
John Torrisi
j**********i@abbvie.com
-
Barbara Razenberg
b***************g@abbvie.com
-
Matthew Galley
m************y@abbvie.com
-
Emily King
e********g@abbvie.com
-
Gentry Lassiter
g*************r@abbvie.com
-
Elena Karpilovski
e***************i@abbvie.com
-
Liz Shea
l******a@abbvie.com
-
Ilke Limoncu
i**********u@abbvie.com
-
Alyssa Rege
a*********e@abbvie.com
-
Raquel Powers
r***********s@abbvie.com
-
Jeremy Picard
j***********d@abbvie.com
-
Adelle Infante
a************e@abbvie.com
-
Todd Bosse
t********e@abbvie.com
-
Joao N Belo
j*********o@abbvie.com
-
Jaquelin Finley
j*************y@abbvie.com
-
Gerlinde Baldauf
g**************f@abbvie.com
-
V Siparis
v*******s@abbvie.com
-
Jenna Hanson
j**********n@abbvie.com
-
David Wagner
d**********r@abbvie.com
-
Isabelle Petatthiolas
i*******************s@abbvie.com
-
Anisha Manix
a**********x@abbvie.com
-
Jacqueline Karis
j**************s@abbvie.com
-
Suzanne Barston
s*************n@abbvie.com
-
Shannelle Fowler
s**************r@abbvie.com
-
Dana Harville
d***********e@abbvie.com
-
Gabrielle Tarbert
g***************t@abbvie.com
-
Susanne Griffiths
s***************s@abbvie.com
-
Larry Peepo
l*********o@abbvie.com
-
Gregory Miley
g***********y@abbvie.com
-
Courtney Fella
c************a@abbvie.com
-
Jonathan Anderson
j***************n@abbvie.com
-
Jenina Nunez
j**********z@abbvie.com
-
Moiz Diwan
m********n@abbvie.com
-
Tym Lindsey
t*********y@abbvie.com
-
Office At
o*******t@abbvie.com
-
Mandie Judy
m*********y@abbvie.com
-
Fabio Lievano
f***********o@abbvie.com
-
Thao T Doan
t*********n@abbvie.com
-
Peter Bacher
p**********r@abbvie.com
-
Birgitta Bjornek
b**************k@abbvie.com
-
Joy Jacksonguilford
j******************d@abbvie.com
-
Rebecca Kohnken
r*************n@abbvie.com
-
Elizabeth Simms
e*************s@abbvie.com
-
Lucas Chavira
l***********a@abbvie.com
-
David Gardner
d***********r@abbvie.com
-
Juliapaige Yuhase
j***************e@abbvie.com
-
Fernando Bastos
f*************s@abbvie.com
-
Yunhao Tan
y********n@abbvie.com
-
Hongjian Zhu
h**********u@abbvie.com
-
Carlos Hader
c**********r@abbvie.com
-
Samira Mawla
s**********a@abbvie.com
-
Fabian Liboschik
f**************k@abbvie.com
-
Petra Grossmann
p*************n@abbvie.com
-
Anna Samokhvalova
a***************a@abbvie.com
-
Dai Feng
d******g@abbvie.com
-
Iain Boomer
i*********r@abbvie.com
-
Alice Chan
a********n@abbvie.com
-
Megana Vatson
m***********n@abbvie.com
-
Amanda Vogel
a**********l@abbvie.com
-
Jun Yu
j****u@abbvie.com
-
Kevin Zowaski
k***********i@abbvie.com
-
Eva Sebestova
e***********a@abbvie.com
-
Kathrin Kuntz
k***********z@abbvie.com
-
Brian Martin
b**********n@abbvie.com
-
Jijie Gu
j******u@abbvie.com
-
Andrew Shaw
a*********w@abbvie.com
-
Florian Dieckmann
f***************n@abbvie.com
-
David Freundel
d************l@abbvie.com
-
Javier Boix
j*********x@abbvie.com
-
Tamer Hanna
t*********a@abbvie.com
-
Diana L Donnellyroberts
d**********************s@abbvie.com
-
Dayoung Yi
d********i@abbvie.com
-
Renee Heuser
r**********r@abbvie.com
-
Blai Coll
b*******l@abbvie.com
-
Muriel Haraoui
m************i@abbvie.com
-
Daniela Haertel
d*************l@abbvie.com
-
Sanjay Bhardwaj
s*************j@abbvie.com
-
Kaisa Raitio
k**********o@abbvie.com
-
Sabine Grote
s**********e@abbvie.com
-
Johanna Castrillon
j****************n@abbvie.com
-
Veronique Paula
v*************a@abbvie.com
-
Christina Lee
c***********e@abbvie.com
-
Gary Chiang
g*********g@abbvie.com
-
Marketta Piskonen
m***************n@abbvie.com
-
Aman Thukral
a**********l@abbvie.com
-
Julie Lepsetz
j***********z@abbvie.com
-
Hannah Martinez
h*************z@abbvie.com
-
Aris Vasilopoulos
a***************s@abbvie.com
-
Ryota Watanabe
r************e@abbvie.com
-
Takao Nito
t********o@abbvie.com
-
Weili He
w******e@abbvie.com
-
Mabel Martinez
m************z@abbvie.com
-
Devin Slagle
d**********e@abbvie.com
-
Eileen Murphy
e***********y@abbvie.com
-
Giuseppina Zarigno
g****************o@abbvie.com
-
Eric Mohler
e*********r@abbvie.com
-
Min Zhang
m*******g@abbvie.com
-
Terhi Pellinen
t************n@abbvie.com
-
Anne Lejon
a********n@abbvie.com
-
Marcello Rinaldi
m**************i@abbvie.com
-
Ryoichi Kiyohara
r**************a@abbvie.com
-
Jillian Griffin
j*************n@abbvie.com
-
Shuai Hao
s*******o@abbvie.com
-
Jessica Feltman
j*************n@abbvie.com
-
Jeffrey Allan
j***********n@abbvie.com
-
Frank Benenati
f************i@abbvie.com
-
Shashank Shekhar
s**************r@abbvie.com
-
Roxann Stubbs
r***********s@abbvie.com
-
Medha Tomlinson
m*************n@abbvie.com
-
Beatriz Samanes
b*************s@abbvie.com
-
Kate Ferrario
k***********o@abbvie.com
-
Nicole Muraca
n***********a@abbvie.com
-
Jay Lucas
j*******s@abbvie.com
-
Helene Villeneuve
h***************e@abbvie.com
-
Pascal Marcoux
p************x@abbvie.com
-
Nathalie Lavoie
n*************e@abbvie.com
-
Theresia Bredenwall
t*****************l@abbvie.com
-
Ric A. Gonzalez
Chairman of the Board & Chief Executive Officer
r************z@abbvie.com
-
Vijay Raghavan
Associate Vice President, Marketing Analytics & Business Insights
v***y@abbvie.com
-
Sanjay Nilapwar
Principal Scientist
s****y@abbvie.com
-
S Nikhil Kumar
Founder
s*******r@abbvie.com
-
Tariq Ghayur
Distinguished Research Fellow
t***q@abbvie.com
-
Axel Arosenius
Psychiatry Specialty Representative
a**l@abbvie.com
-
James Holdsworth
Architect, Technology II
j***s@abbvie.com
-
Arminda Montero
Program Manager, Global Supply Chain QA
a*****a@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
talentacquisition@abbvie.com
-
Unclassified inbox
AbbvieCDO@abbvie.com
-
Unclassified inbox
privacydsr@abbvie.com
-
Unclassified inbox
info-cz@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
switzerland@abbvie.com
-
Unclassified inbox
orders@abbvie.com
-
Unclassified inbox
medical_info_spain@abbvie.com
-
Unclassified inbox
safety-cz@abbvie.com
-
Unclassified inbox
plsproductsurveillanceteam@abbvie.com
-
Unclassified inbox
hrconnect.northamerica@abbvie.com
-
Unclassified inbox
abbviepaa@abbvie.com
-
Unclassified inbox
managepd_support_it@abbvie.com
-
Unclassified inbox
library@abbvie.com
-
Unclassified inbox
job-opportunities@abbvie.com
-
Unclassified inbox
sp-assuntos_regulatorios@abbvie.com
-
Unclassified inbox
cs-germany@abbvie.com
-
Customer Service
service@abbvie.com
-
Unclassified inbox
info.de@abbvie.com
-
Unclassified inbox
alan.rubin@abbvie.com
-
Unclassified inbox
adeline.teo@abbvie.com
-
Unclassified inbox
melanie.cohen@abbvie.com
-
Unclassified inbox
nancy.vangeys@abbvie.com
-
Unclassified inbox
china_pv@abbvie.com
Medtronic
Medtronic develops healthcare technology solutionsShow more... for various medical conditions.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active
56 Emails
0 Phones
Main email format: sarah.smith@medtronic.com (83.3%)
-
Omar Ishrak
CEO
o**r@medtronic.com
-
Markowski
Senior Manager
m*******i@medtronic.com
-
Robert Vigersky
Medical Director
r*************y@medtronic.com
-
Ben Thom
Senior Regional Contract Manager
b******m@medtronic.com
-
Ludmila Larson
Senior Contract & Data Analyst
l************n@medtronic.com
-
Karen Parkhill
EVP & Chief Financial Officer
k************l@medtronic.com
-
Terry Menebroker
Manager Contract Development at Medtronic
t**************r@medtronic.com
-
Jeff Scarborough
Regional Sales Manager, Cardiac and Vascular Group, Western Canada
j**************h@medtronic.com
-
Geoffrey Martha
Chairman & Chief Executive Officer
g*************a@medtronic.com
-
Milo Metcalf
Vice President of Contract Manufacturing
m**********f@medtronic.com
-
Gerard Kilcommins
Vice President Global Operations & General Manager Galway Site
g**************s@medtronic.com
-
Stewart Mccall
Enabling Technologies District Sales Manager
s************l@medtronic.com
-
Diana Murazzo
Principal Contract Analyst
d***********o@medtronic.com
-
Crosby Hull
Associate Sales Representative, Spine
c*********l@medtronic.com
-
Fabiënne Keulers
Clinical Study Assistant CRHF
f**************s@medtronic.com
-
Marc Vanhoutte
Therapy Specialist pain
m************e@medtronic.com
-
Melissa Engelhart
Sr. Director, Global Brand - Corporate Marketing
m***************t@medtronic.com
-
Gisele Osborn
Principal Quality Engineer, Post Market Vigilance
g***********n@medtronic.com
-
Scott Vanderwerf
s**************f@medtronic.com
-
Eric Foster
e*********r@medtronic.com
-
Julie Fischbach
j*************h@medtronic.com
-
Akash Beejawat
a************t@medtronic.com
-
Åsa Grosso
a********o@medtronic.com
-
Sheila Minske
Director of Global Supply Chain Strategy and Innovation at Medtronic
s***********e@medtronic.com
-
Francesca Battistoni
f******************i@medtronic.com
-
Braden Hopps
b**********s@medtronic.com
-
Peter Byron
p*********n@medtronic.com
-
Roy Wilsker
r*********r@medtronic.com
-
Chas Pall
c*******l@medtronic.com
-
Kevin Kelley
Director of Sustainability & Business Development
k**********y@medtronic.com
-
Eoin Keane
e********e@medtronic.com
-
Ben Karel
b*******l@medtronic.com
-
Stephane Moreau
s*************u@medtronic.com
-
Barbara Sandovalabsher
b********************r@medtronic.com
-
Teresita Obra
t***********a@medtronic.com
-
Giacomo Iacomino
g**************o@medtronic.com
-
Raheel Ahmad
r**********d@medtronic.com
-
Alessandro Antico
a***************o@medtronic.com
-
Gal Noiman
Import, Export & Logistics Coordinator
g********n@medtronic.com
-
Daniele Guzzi
d***********i@medtronic.com
-
Rob Ten Hoedt
Senior Vice President & President, EMEA & Canada
r****h@medtronic.com
-
Paul J. Robinson
Director of Operations
p*************n@medtronic.com
-
Jeff Kramer
Vice President, Research and Technology, RTG
j**f@medtronic.com
-
Todd Gillenwater
Senior Director, Government Affairs
t**d@medtronic.com
-
Eileen Sheil
Vice President Communications
e**********l@medtronic.com
-
Alfred E. Mann
Founder
a*******m@medtronic.com
-
Daniel Grossman
Founder
d****l@medtronic.com
-
Earl Bakken
Founder
e*********n@medtronic.com
-
Palmer Hermundslie
Founder
p****************e@medtronic.com
-
Marc Stein
Technical Fellow and Senior Member
m********n@medtronic.com
-
Sean Lennon
CIO
s*********n@medtronic.com
-
Unclassified inbox
michelle.r.claypool@medtronic.com
-
Unclassified inbox
RS.MedtronicAcademy@medtronic.com
-
Unclassified inbox
customerservice.portugal@medtronic.com
-
Unclassified inbox
julie.a.price@medtronic.com
-
Unclassified inbox
leidy.zuluaga@medtronic.com
Pfizer Venture Investments
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
50 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.7%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
p****u@pfizer.com
-
Andrew Nager
a**********r@pfizer.com
-
Chikita Sobti
c***********i@pfizer.com
-
Professionalerika Schremp
p***********************p@pfizer.com
-
Unclassified inbox
samuel.thevasagayam@pfizer.com
-
General Inquiries
alfredo.chi@pfizer.com
-
Unclassified inbox
andrew.nager@pfizer.com
-
Unclassified inbox
chikita.sobti@pfizer.com
-
Unclassified inbox
professionalerika.schremp@pfizer.com
Merck
Merck is a biopharmaceutical company that offers mShow more...edicines and vaccines for various diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
49 Emails
0 Phones
Main email format: sarah_smith@merck.com (75.0%)
-
Phillip Samayoa
Associate Director, MRL Ventures
p******s@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Eliav Barr
Vice President, Infectious Diseases
e********r@merck.com
-
Peter Honigmann
p*************n@merck.com
-
Rob Davis
r*******s@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d*****i@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d****i@merck.com
-
Renee Suhr
r********r@merck.com
-
Caroline Litchfield
c*****************d@merck.com
-
Todd Herman
t*********n@merck.com
-
Todd Herman
t*********n@merck.com
-
Eunkyung Kauh
e***********h@merck.com
-
Cameron Downie
c************e@merck.com
-
Cameron Downie
c************e@merck.com
-
Martin Khun
m*********n@merck.com
-
Martin Khun
m*********n@merck.com
-
Joe Volpe
j**********e@merck.com
-
Lubomir Kamensky
l**************y@merck.com
-
Carolina Colella
c**************a@merck.com
-
Rachel Parise
PhD Candidate - Analytical Chemistry Reseacher
r***********e@merck.com
-
Peter Dudek
Associate
p*********k@merck.com
-
Marc Gailhardou
a VP Global Oncology Strategy at Merck
m*************u@merck.com
-
Jieyun Hao
HR Business Partner
j********o@merck.com
-
Francesca Poggio
f**************o@merck.com
-
Ken Friesen
k*********n@merck.com
-
Austin Snook
a**********k@merck.com
-
Roberta Corsi
r***********i@merck.com
-
Vishal Sahni
Venture Capital advisory committee member, Biofund II
v**********i@merck.com
-
John Minehane
Assistant Production Manager
j***********e@merck.com
-
Cheryl Donnelly
c*************y@merck.com
-
Courtney Ronaldo
c**************o@merck.com
-
Tracy Clemmer
t************2@merck.com
-
Harry Herar
Sales Representative
h*********r@merck.com
-
Andrei Manica
a***********a@merck.com
-
Sergey Zverev
s***********v@merck.com
-
Rehan A Khan
r********n@merck.com
-
Kevin Ali
k*******i@merck.com
-
Kevin Sharpe
k**********e@merck.com
-
Heather Rakestraw
h***************w@merck.com
-
Cedric Grand-Pierre
c****************e@merck.com
-
Joyce. Pennings
j************s@merck.com
-
Anneke Rietveld
Key Account Manager
a*************d@merck.com
-
Kathleen Cuddy
k************y@merck.com
-
Unclassified inbox
estanislao_meza@merck.com
-
Unclassified inbox
alain_boisvert@merck.com
-
Unclassified inbox
retailteam@merck.com
-
Unclassified inbox
rgball@merck.com
-
Unclassified inbox
kathleen.cuddy@merck.com
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
49 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
-
Unclassified inbox
ldad@novonordisk.com
-
Unclassified inbox
myce@novonordisk.com
-
Unclassified inbox
mtwg@novonordisk.com
-
Unclassified inbox
kbjo@novonordisk.com
-
Unclassified inbox
zast@novonordisk.com
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
44 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laShow more...boratory equipment company that provides a wide range of scientific products and services.
Specialized In: Biotechnology, Cloud Computing, Coaching & Consulting, Healthcare & Medical, Technology & Software
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1956
Company Type: For Profit
Stock Symbol: BMV:TMO
Operating Status: Active
36 Emails
1 Phones
Main email format: sarah.smith@thermofisher.com (96.4%)
-
Becky Moore
Product Manager
m***e@thermofisher.com
-
Kim Baltier
Vice President, Global Commercial Operations Biosciences
k*********r@thermofisher.com
-
Bob Hammerton
b***********n@thermofisher.com
-
Nicole Berardi
n************i@thermofisher.com
-
Alexander J Picun
Associate Project Manager
a*************n@thermofisher.com
-
Karen Redd
Sales Director, Area West Immunodiagnostic Division
k********d@thermofisher.com
-
Kevan Miller
Director, Commercial Excellence & Compliance
k**********r@thermofisher.com
-
Charles Parker
Telecommunications Technician
c************r@thermofisher.com
-
Patrik Magnusson
Vice President, Specialty Diagnostics Group, Asia Pacific & Emerging Markets
p**************n@thermofisher.com
-
Mark A Alleman
Global Commercial Leader, Digital Science
m**********n@thermofisher.com
-
Richard Milne
Vice President and Global Leader of eBusiness
r***********e@thermofisher.com
-
Sasha Vlassov
Senior Manager R&D
s***********v@thermofisher.com
-
Richard Milne
Vice President and Global Leader of eBusiness
v***************o@thermofisher.com
-
Melody Savea
Senior Director OEM and Licensing, Molecular Biology, Protein and Cell Analysis
m**********a@thermofisher.com
-
Michelle Logan
m************n@thermofisher.com
-
Louise Wilson
Analytical Chemist at Johnson Matthey
l***********n@thermofisher.com
-
Alicia Rosol
a**********l@thermofisher.com
-
Tiffani Manolis
t*************s@thermofisher.com
-
Art Lee
a*****e@thermofisher.com
-
Dimitris Gkirlemis
d****************s@thermofisher.com
-
Enrico Vietri
Principal Consultant
e***********i@thermofisher.com
-
Kim Chai
k******i@thermofisher.com
-
Anand Das
Technology Advisor
a*******s@thermofisher.com
-
Lisa Averns
l*********s@thermofisher.com
-
Erdem Karabulut
Postdoctoral Researcher
e*************t@thermofisher.com
-
Walter Dernelle
w*************e@thermofisher.com
-
Dorine Laheij
d***********j@thermofisher.com
-
Katya Rodriguez
Senior Manager, Global Trade Compliance
k*************z@thermofisher.com
-
Suzanne Graham
Senior Director, Global Business & Sales Development, Electron Microscopy at Thermo Fisher Scientific
s************m@thermofisher.com
-
Jeff Bonevich
j***********h@thermofisher.com
-
Lisa Bakens
l*********s@thermofisher.com
-
Unclassified inbox
orders@thermofisher.com
-
Unclassified inbox
nniweborderconfirmations@thermofisher.com
-
Unclassified inbox
lisa.bakens@thermofisher.com
-
Unclassified inbox
readycheckgotx@thermofisher.com
-
Unclassified inbox
safendhealthyschools@thermofisher.com
Gilead Sciences
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
34 Emails
0 Phones
Main email format: sarah.smith@gilead.com (53.6%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Kelsey Reedy
Talent Advisor
k**********y@gilead.com
-
Anhquan Nguyen
Senior Research Associate
a*****n@gilead.com
-
Jack Wessel
Associate General Counsel, IP
j*********l@gilead.com
-
Patrick Loerch
Senior Vice President, Clinical Data Science
p*****h@gilead.com
-
Rashad Burgess
Regional Sales Director
r************s@gilead.com
-
Brian Peters
Senior Director, Procurement
f*****n@gilead.com
-
Don Dennis
Director
d********s@gilead.com
-
Elysia K
Sr. Clinical Trial Management Associate
e******k@gilead.com
-
Merdad Parsey
EVP & CMO Gilead Sciences
m*****y@gilead.com
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing,
m**********h@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Alexis Mehta6
a***********6@gilead.com
-
Gary Tully
Head of Legal Operations
g**y@gilead.com
-
Joel Bercu
Associate Director
j****u@gilead.com
-
Teresa Wang
Director, Investor Relations
w**g@gilead.com
-
Daniel O'Day
Chairman and Chief Executive Officer
d****l@gilead.com
-
Jacopo Andreose
SVP Intercontinental and Global Patient Solutions
j****o@gilead.com
-
Michael L. Riordan
Founder
m***************n@gilead.com
-
Mark Hill
Senior Vice President & CIO
m**k@gilead.com
-
Wenjun Ouyang
Senior Vice President
w****n@gilead.com
-
Anthony Mire-Sluis
Senior Vice President Quality
a**********s@gilead.com
-
Bob Mecca
Senior Vice President Finance
b*b@gilead.com
-
Unclassified inbox
public_affairs@gilead.com
-
Unclassified inbox
bernard.murray@gilead.com
-
Unclassified inbox
andre.luescher@gilead.com
-
Unclassified inbox
20careers@gilead.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
35 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
Joachim Hoechel
j*************l@bayer.com
-
Chikako Takayama
c**************a@bayer.com
-
Kumiko Tanabe
k***********e@bayer.com
-
General Inquiries
info@bayer.com
-
Unclassified inbox
olaf.zoellner.b@bayer.com
-
Unclassified inbox
salvador.llado@bayer.com
-
Unclassified inbox
joachim.hoechel@bayer.com
-
Unclassified inbox
chikako.takayama@bayer.com
-
Unclassified inbox
kumiko.tanabe@bayer.com
Roche
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
36 Emails
0 Phones
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
Thomas Schinecker
t***************r@roche.com
-
Brad Moore
b********e@roche.com
-
Andre Hoffmann
a************n@roche.com
-
Darla Ramsey
d**********p@roche.com
-
Kevin Bylinski
k************i@roche.com
-
Abed Sabra
a********a@roche.com
-
Nikolce Gjorevski
n***************i@roche.com
-
David Barton
d********1@roche.com
-
Mark Adam
m*******m@roche.com
-
Andrzej Dobrowolski
a*****************i@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Nancy Yuan
n********n@roche.com
-
Kadir Demirtas
k************s@roche.com
-
Thierry Lave
Global Head DMPK and TOX Project Leaders and Modeling and Simulation
t**********e@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com
-
Unclassified inbox
jana.vichova@roche.com
-
Unclassified inbox
antonio.cruz@roche.com
-
Unclassified inbox
ns@roche.com
AstraZeneca
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
32 Emails
0 Phones
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Richard Gallo
Oncology Contract Strategy Manager
r***********o@astrazeneca.com
-
Nabil Dharsi
Medical Science Liaison, Hematology
n**********i@astrazeneca.com
-
Dan Wygal
Executive Director of Contract and Channel Strategy
d*******l@astrazeneca.com
-
Claudia Lamp
Contract Sr Patient Safety Scientist
c**********p@astrazeneca.com
-
Tom Keith-Roach
President, Astrazeneca UK
t*************h@astrazeneca.com
-
Mary Richardson
Global Publications Director, OBU
m*************n@astrazeneca.com
-
Matthew Roe
VP, Head of Early Clinical Development - Cardiovascular, Renal, and Metabolic
m*********e@astrazeneca.com
-
Jennifer Schmoll
Global Marketing Director-Diabetes
j**************l@astrazeneca.com
-
Lee Bennett
Associate Regulatory Project Director
l*********t@astrazeneca.com
-
Jasmine Jansens
Clinical Site Monitor
j*************s@astrazeneca.com
-
Stephanie Kenney
Global Head of Corporate Affairs, Cardiovascular Renal and Metabolism
s********************i@astrazeneca.com
-
Giovanni Melillo
Vice President - Immuno-oncology, Global Medical Affairs
g**************o@astrazeneca.com
-
Karina Estevez
Human Resources Global Graduate Associate
k************z@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
David Bock
d********k@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com
-
General Inquiries
takemi.sunouchi@astrazeneca.com
-
Unclassified inbox
astrazeneca.india@astrazeneca.com
-
Unclassified inbox
opsmexicoprocurement@astrazeneca.com
-
Unclassified inbox
speakerprogramsmailbox@astrazeneca.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
Bristol-Myers Squibb
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
30 Emails
0 Phones
Main email format: sarah.smith@bms.com (95.5%)
-
John damonti
Foundation President
d******j@bms.com
-
Ron Behling
r************g@bms.com
-
Devin Carsdale
d************e@bms.com
-
Suketu Desai
s**********i@bms.com
-
Zelalem Demere
z************e@bms.com
-
Eva Dion
e******n@bms.com
-
Dina Akbar
d********r@bms.com
-
Jaya Saigal
j*********l@bms.com
-
Danish Sheikh
d***********h@bms.com
-
Trisha Putro
t**********o@bms.com
-
Xue Li
x****i@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
Sanna Viitanen
s************n@bms.com
-
Unclassified inbox
drugsafety@celgene.com
-
Unclassified inbox
carmen.m.lopez@bms.com
-
Unclassified inbox
eduardo.uribe@bms.com
-
Unclassified inbox
sanna.viitanen@bms.com
-
Unclassified inbox
bd-onchema@bms.com
-
Unclassified inbox
bd-ct@bms.com
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
29 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Jenna Fields
j**********s@ucsf.edu
-
Anthony Digiorgio
a***************o@ucsf.edu
-
Judith Kunitz
j***********z@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
-
Unclassified inbox
ucsf.msa.juma@ucsf.edu
-
Unclassified inbox
david.fernandezlopez@ucsf.edu
-
Unclassified inbox
jenna.fields@ucsf.edu
-
Unclassified inbox
anthony.digiorgio@ucsf.edu
-
Unclassified inbox
judith.kunitz@ucsf.edu
Celgene
Celgene discovers, develops and commercializes innShow more...ovative therapies to treat cancer and immune-inflammatory-related diseases.
Specialized In: Biotechnology, Healthcare & Medical
Acquired by: Bristol-Myers Squibb
Business Type: Delisted
Employees: 10001+
Last Investment Activity: May 24, 2024
Founded Date: 1986
Number of Exits: 31
Company Type: For Profit
Stock Symbol: NASDAQ:CELG
Operating Status: Active
24 Emails
0 Phones
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Ron Behling
r************g@bms.com
-
Devin Carsdale
d************e@bms.com
-
Suketu Desai
s**********i@bms.com
-
Zelalem Demere
z************e@bms.com
-
Eva Dion
e******n@bms.com
-
Dina Akbar
d********r@bms.com
-
Jaya Saigal
j*********l@bms.com
-
Danish Sheikh
d***********h@bms.com
-
Trisha Putro
t**********o@bms.com
-
Xue Li
x****i@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
Unclassified inbox
drugsafety@celgene.com
GlaxoSmithKline
GlaxoSmithKline develops and markets products in tShow more...he areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@gsk.com (94.1%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Ukirl Servicehr
u*************r@gsk.com
-
Unclassified inbox
askus@gsk.com
-
Unclassified inbox
manuel.m.bermudez@gsk.com
-
Unclassified inbox
carol_a_jennings@gsk.com
-
Human Resources Team
ukirl.servicehr@gsk.com
-
Unclassified inbox
id.cpa@gsk.com
Quintiles
Quintiles is a provider of biopharmaceutical develShow more...opment and commercial outsourcing services for drugs on the market.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active
23 Emails
1 Phones
Main email format: sarah.smith@quintiles.com (100.0%)
-
Saida El Maslouhi, MSc.
Director Early Clinical Development
s**************i@quintiles.com
-
Darren Coish
d**********h@quintiles.com
-
Kimmy Yang
Senior Clinical Research Associate
k********g@quintiles.com
-
Priya Gamre
Assistant Medical Data Review Manager
p*********e@quintiles.com
-
Lucia Novoa
Clinical Team Leader
l*********a@quintiles.com
-
Aisha Keller
a**********r@quintiles.com
-
Brian Kelly
Senior Advisor
p************k@quintiles.com
-
Jara Soltero
j**********o@quintiles.com
-
Hicham Benhaddi
h*************i@quintiles.com
-
Alistair Grenfell
President North Europe, Middle East, Africa and South Asia
a***************l@quintiles.com
-
Diane Brescia
Sr. Recruiter
d***********a@quintiles.com
-
Parag Phad
p********d@quintiles.com
-
Michelle Wilken
Director of Commercial Strategy
m*************n@quintiles.com
-
Jeff Fusco
j********o@quintiles.com
-
Cindy Lam
c*******m@quintiles.com
-
Patrick Daly
Executive In Residence
p**********y@quintiles.com
-
Debalina Pani
d***********i@quintiles.com
-
Fatemeh Tahavori
f**************i@quintiles.com
-
Amarpreet Chawla
a**************a@quintiles.com
-
Nabeel Abdallah
n*************h@quintiles.com
-
Katarina Moulinet
k***************t@quintiles.com
-
Unclassified inbox
mallika.bhaskar@quintiles.com
-
Unclassified inbox
matthew.frese@quintiles.com
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
21 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
Amgen
Amgen is a biotechnology company that develops andShow more... manufactures human therapeutics for various illnesses and diseases.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active
27 Emails
0 Phones
Main email format: ssmith@amgen.com (88.9%)
-
Esteban Santos
Executive Vice President, Operations
e******s@amgen.com
-
Bob Bradway
Chief Executive Officer
b******y@amgen.com
-
Angelina Finch
Marketing Director, U.S. Value & Access
a****h@amgen.com
-
Jack Ryan
Operations Manager
j***n@amgen.com
-
Gladys Nunez
Director
g**********z@amgen.com
-
Gladys Nunez
Director
g****z@amgen.com
-
Kathrine Parrish
Patient Access and Reimbursement Manager
k******h@amgen.com
-
Chen Xiaoyue
Post doctoral research fellow in Oncology department
c******e@amgen.com
-
Rosalyn Rivera
Director, Contract Manufacturing
r*****a@amgen.com
-
Nicola Magill
Senior Manager / Principal Engineer
n*****l@amgen.com
-
Sheela Kotagiri
Project Manager
s*******i@amgen.com
-
Ingrid Darmody
Senior Associate QA
i******y@amgen.com
-
Sergio Rodriguez Mallada
QA Specialist
s******a@amgen.com
-
Wendy Kusler
w*****r@amgen.com
-
Krupali Patel
k****l@amgen.com
-
Susan Sweeney
s******y@amgen.com
-
Angelinda Chen
Gender Lens Impact Investing Fellow
a***n@amgen.com
-
Daniel Lu
d*u@amgen.com
-
Rex Atienza
r******a@amgen.com
-
Unclassified inbox
HCCIME@amgen.com
-
Unclassified inbox
medinfocanada@amgen.com
-
Unclassified inbox
amgenmediarelations@amgen.com
-
Unclassified inbox
thood@amgen.com
-
Unclassified inbox
vinsonl@amgen.com
-
Unclassified inbox
joepr@amgen.com
-
Unclassified inbox
u003ejoepr@amgen.com
-
Unclassified inbox
caring@amgen.com
Moderna
Moderna Therapeutics is a biotechnology company thShow more...at specializes in drug discovery and drug development based on messenger RNA.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank
24 Emails
0 Phones
Main email format: sarah.smith@modernatx.com (100.0%)
-
Huijuan Li
Head, Analytical Development
h********i@modernatx.com
-
Kerry Salandria
Associate Director, Analytical Operations
k*************a@modernatx.com
-
Dean Geribo
Head of Corporate Security
d*********o@modernatx.com
-
Michael Wythe
Senior Director
m***********e@modernatx.com
-
Spyros Chalkias
Senior Medical Director, Clinical Development, Infectious Disease - Public Health Vaccines
s*************s@modernatx.com
-
Galit Alter
VP of Immunology Research
g*********r@modernatx.com
-
Tina Earl
Sr. Specialist, Quality Assurance
t*******l@modernatx.com
-
Francesca Ceddia
SVP Respiratory Vaccines, Global Medical
f**************a@modernatx.com
-
Lilly Naqvi
Engineer II
l*********i@modernatx.com
-
Seymour De Picciotto
Scientific Director
s*****************o@modernatx.com
-
Tatiana Novobrantseva
Chief Scientific Officer, Immuno-Oncology Research
t*******************a@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
j*********s@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
s***********y@modernatx.com
-
Nidal El Assi
Associate Director Of Lab Operations
n********i@modernatx.com
-
Lavina Talukdar
l*************r@modernatx.com
-
Shannon Thyme Klinger
Chief Legal Officer at Moderna
s*************r@modernatx.com
-
Gamal Elfatarany
g**************y@modernatx.com
-
Kate Jeffrey
k**********y@modernatx.com
-
Katriona Methven
k**************n@modernatx.com
-
Unclassified inbox
WeCare@modernatx.com
-
Unclassified inbox
Grace.Chen@modernatx.com
-
General Inquiries
info@modernatx.com
-
Unclassified inbox
stephane.bancel@modernatx.com
-
Unclassified inbox
careers@modernatx.com
Seagen
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
23 Emails
0 Phones
Main email format: ssmith@seagen.com (37.5%)
-
Guy Padbury
Senior Vice President, Translational Sciences
g******y@seagen.com
-
Bryce Mansfield
Executive Director, R&D Quality
b********d@seagen.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k*****i@seagen.com
-
Davina Sparks Henderson
Sr Manager. Field Reimbursement
d********n@seagen.com
-
Virginie Oble Bouvet
v***e@seagen.com
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
Scott Orchard
Senior Vice President and Associate General Counsel, Head of Transactional Law
s***********d@seagen.com
-
Swapnil Bhargava
Director, BioProcess Development
s*****l@seagen.com
-
Wendel Doubleday
Sr. Director, Chemical Development
w********y@seagen.com
-
Mark Cooley
Executive Director, IT Strategy and Operations
m**k@seagen.com
-
Monique M. Greer
Vice President, Corporate Communications
m*******r@seagen.com
-
Michael Gerstle
Director
m*****l@seagen.com
-
Clay Siegall
Founder
c**********l@seagen.com
-
Qi Jiang
Senior Vice President, Head of Biometrics
qi@seagen.com
-
Peggy Pinkston
Senior Vice President, Investor Relations
p************n@seagen.com
-
Stephan Thebault
Senior Vice President, Global Head of Quality
s**************t@seagen.com
-
General Inquiries
contact@seagen.com
-
Unclassified inbox
pcarter@seagen.com
-
Unclassified inbox
serviceclients@seagen.com
-
Unclassified inbox
ktreutlein@seagen.com
-
Unclassified inbox
pwalters@seagen.com
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jul 8, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
23 Emails
0 Phones
Main email format: sarah.smith@lilly.com (66.7%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
b********e@lilly.com
-
Nmohamed Elsayed
n**************d@lilly.com
-
General Inquiries
kuga_atsushi@lilly.com
-
Unclassified inbox
hernandez_jorge_david@lilly.com
-
Unclassified inbox
rodriguez_mauricio_a@lilly.com
-
Unclassified inbox
coskun_tamer@lilly.com
-
Unclassified inbox
nmohamed.elsayed@lilly.com
Tempus
Tempus is a technology company advancing precisionShow more... medicine through the practical application of artificial intelligence in healthcare.
Specialized In: AI & Machine Learning, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 501-1000
Rounds: Debt Financing
Last Investment Activity: Mar 27, 2024
Founded Date: 2015
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
25 Emails
2 Phones
Main email format: sarah.smith@tempus.com (82.4%)
-
Ryan Fukushima
Chief Operating Officer
r**n@tempus.com
************0
-
Martin Stumpe
Chief of AI
m***********e@tempus.com
***********9
-
Bogdan Ivan
b*********n@tempus.com
-
Lauren Silvis
Board of Directors
l***********s@tempus.com
-
Nicole Bean
Associate Director of Promotional Marketing ✦ Corporate Brand Identity ✦ Social Media Marketing
n*********n@tempus.com
-
Laura Pausch
Commercial Operations Associate
l***a@tempus.com
-
Rohini Yadav
Senior Software Engineer
r**********v@tempus.com
-
Daria Tarasova
Senior Software Engineer
d************a@tempus.com
-
Colin Meret
Senior Site Reliability Engineer
c*********t@tempus.com
-
Eric Lefkofsky
Founder
e**c@tempus.com
-
Riccardo Miotto
Director of Machine Learning
r*************o@tempus.com
-
Shane Colley
CTO
s**********y@tempus.com
-
Erik Phelps
Executive Vice President, Chief Administrative and Legal Officer
e*********s@tempus.com
-
Geoffrey Schau
g************u@tempus.com
-
Dina Pontarelli
d*************i@tempus.com
-
Richard Klinghoffer
Senior Vice President
r*****************r@tempus.com
-
James Chen
Senior Vice President, Medical Informatics
j********n@tempus.com
-
Admin Team
admin@tempus.com
-
Customer Service
support@tempus.com
-
General Inquiries
contact@tempus.com
-
General Inquiries
feedback@tempus.com
-
General Inquiries
help@tempus.com
-
Media Relations
media@tempus.com
-
Unclassified inbox
tempus@tempus.com
-
Unclassified inbox
kenya@tempus.com
Lonza
Lonza Group supplies products and services to pharShow more...maceutical and agrochemical industries.
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1897
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:LONN
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@lonza.com (100.0%)
-
Alice Harrison
Global Technical Director
a************n@lonza.com
-
Wolfgang D)
global Project Manager (Master Black Belt)
w***********k@lonza.com
-
Matthew Hall
Western Regional Sales Manager
m**********l@lonza.com
-
Donald Sohn, CFA
d*********n@lonza.com
-
Paul Tastenhoye
Program Management Leader Peptides/Braine
p*************e@lonza.com
-
Peter Aken
Global Head of Antifouling Paints and Aquaculture
p***********n@lonza.com
-
Klea Lenja
k********a@lonza.com
-
Peter Groenewege
Director Innovation Strategy & PMO (Capsules & Health ingredients)
p**************e@lonza.com
-
Eric Blomgren
Associate Director, Business Development
e***********n@lonza.com
-
Cameron Kadleck
Scientist
c*************k@lonza.com
-
Chris Maskell
Head Of Program Management
c***********l@lonza.com
-
Thomas Stuenkel
t*************l@lonza.com
-
Elissa Goldstein
e**************n@lonza.com
-
Wolfgang Zimmerer
z***************g@lonza.com
-
Leslie Turville
l*************e@lonza.com
-
Guangzhou Biologics
g*****************s@lonza.com
-
Bioscience China
b**************a@lonza.com
-
General Inquiries
info@lonza.com
-
Admin Team
admin@lonza.com
-
General Inquiries
contact@lonza.com
-
Unclassified inbox
chentwok.lim@lonza.com
-
Unclassified inbox
guixian.hu@lonza.com
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 6, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discoveryShow more... and development of small molecule drugs for the treatment of serious diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah_smith@vrtx.com (64.3%)
-
Thomas Carney
Manager (GMP facility focus), Project Management Office, Global Capital Project Management
t***********y@vrtx.com
-
Gillian
Vice President, Strategic Operations, Regulatory Affairs and Quality
g@vrtx.com
-
Reshma Kewalramani
CEO and President
r****************i@vrtx.com
-
Javier Coindreau
VP Global Strategy Lead - Medical Affairs
j**************u@vrtx.com
-
Uma Raut
Director Global Regulatory Affairs, Cell and Gene Therapy
u******t@vrtx.com
-
Michele Bellandi
Vice President International Commercial
m**************i@vrtx.com
-
Elena Minichiello
Associate Director, Market Access Strategy and Planning
e***************o@vrtx.com
-
Rabah Chibane
Operations Supervisor
r***********e@vrtx.com
-
Robin Bean
Site Activation Manager
r********n@vrtx.com
-
Joshua Chen
VP Biostatistics
j*s@vrtx.com
-
Mark Yu
Senior Research Associate
m*****u@vrtx.com
-
Isaac Vasanthkumar
i****************r@vrtx.com
-
Guoxiang Ruan
g***********n@vrtx.com
-
Phillip Snyder
p************r@vrtx.com
-
Mac Johnson
Senior Director, Research, Vertex Pharmaceuticals
m*********n@vrtx.com
-
Morrey Atkinson
m*************n@vrtx.com
-
General Inquiries
mediainfo@vrtx.com
-
Unclassified inbox
cherif_benattia@vrtx.com
-
Unclassified inbox
chambers@vrtx.com
-
Unclassified inbox
gert_devoer@vrtx.com
-
Unclassified inbox
hanyu_zhu@vrtx.com
-
Unclassified inbox
panggao_duan@vrtx.com
HCA
Hospital Corporation of America (HCA) provides heaShow more...lthcare services in locally managed facilities in 20 states in the U.S. and England.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: Nov 22, 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:HCA
Operating Status: Active
Investor Type: Micro VC, Venture Capital
15 Emails
0 Phones
Main email format: sarah.smith@hcahealthcare.com (100.0%)
-
Eun So
e****o@hcahealthcare.com
-
Rhonda Kashlan
Registered Nurse
r************n@hcahealthcare.com
-
Priscilla Duncan
Sales Operations Manager- Home Health
p**************n@hcahealthcare.com
-
Daren Pfeifer
Director of EMS Relations
d***********r@hcahealthcare.com
-
Dean Carucci
Division Controller - Richmond Division
d**********i@hcahealthcare.com
-
Cindy Kurzrock
c************k@hcahealthcare.com
-
Elsa Vega
Associate Recruiter
e*******a@hcahealthcare.com
-
Janice Lamy
j*********y@hcahealthcare.com
-
Debra Franklin
d************n@hcahealthcare.com
-
Jackie Price
Market Director, Clinical Professional Development
j**********e@hcahealthcare.com
-
Isaiah Zirkle
Chief Operating Officer
i***********e@hcahealthcare.com
-
Sharmen Jackson
Pharmacist
s*************n@hcahealthcare.com
-
Vicki Patterson
v*************n@hcahealthcare.com
-
Diego Arboleda
Manager
d************a@hcahealthcare.com
-
William Vicinanza
william.vicinanza@hcahealthcare.com
-
General Inquiries
info@hcahealthcare.com
LabCorp
Labcorp specializes in providing physicians with lShow more...aboratory tests.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 20, 2024
Founded Date: Sep 5, 1978
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:LH
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@labcorp.com (72.7%)
-
Araceli Reyes
Divisional Medical Director, Northeast Division
a***********s@labcorp.com
-
Ron Wojewucki
r***********i@labcorp.com
-
Wendy
w@labcorp.com
-
Ruth Koester
r**********r@labcorp.com
-
Dan Gudat
g****d@labcorp.com
-
Gregory Janis
j****g@labcorp.com
-
Brittini Richards
b***************s@labcorp.com
-
Lisa Horton
l*********n@labcorp.com
-
Carl Warner
c*********r@labcorp.com
-
Louis Norton
l**********n@labcorp.com
-
Holle Ho
h******o@labcorp.com
-
Lisa Pfefferle
p*****l@labcorp.com
-
Vera Maes
m***v@labcorp.com
-
Drew Barile
Venture Capitalist Interviewer & Story Producer/ Brand Ambassador
bd@labcorp.com
-
Customer Service
LCWebsiteSupport@labcorp.com
-
Unclassified inbox
koester@labcorp.com
Regeneron
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
m*********e@regeneron.com
-
Joseph Brown2
j***********2@regeneron.com
-
Chenguang Wang
c************g@regeneron.com
-
Rena Goins
r********s@regeneron.com
-
Unclassified inbox
thomas.daly@regeneron.com
-
Unclassified inbox
david.glass@regeneron.com
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
22 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
-
Unclassified inbox
preverification@fulgentgenetics.com
-
Unclassified inbox
applyjob@fulgentgenetics.com
-
Unclassified inbox
ajariwala@fulgentgenetics.com
-
Unclassified inbox
rblake@fulgentgenetics.com
-
Customer Service
labservices@fulgentgenetics.com
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceuticalShow more... company that identifies, develops and commercializes innovative treatments.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@jazzpharma.com (100.0%)
-
Bruce Cozadd
Chief Executive Officer
b**********d@jazzpharma.com
-
Charlotte Nortvedt
c****************t@jazzpharma.com
-
Sam Hills
Global Workplace / Facilities Manager
s*******s@jazzpharma.com
-
Remy Sakkers
r**********s@jazzpharma.com
-
Lynette Thomas
l************s@jazzpharma.com
-
James Cekola
Corporate Counsel, Intellectual Property Litigation
j**********a@jazzpharma.com
-
Valmira Hoxhaj
v************j@jazzpharma.com
-
Todd Johnson
t**********n@jazzpharma.com
-
Robert Fell
r*********l@jazzpharma.com
-
Temire Bobegbe
t************e@jazzpharma.com
-
Kevin Jaron
k*********n@jazzpharma.com
-
Erin Chenault
e***********t@jazzpharma.com
-
Maria Heinrich
m************h@jazzpharma.com
-
General Inquiries
investorinfo@jazzpharma.com
-
General Inquiries
contact@jazzpharma.com
-
Unclassified inbox
jeffrey.tobias@jazzpharma.com
Covidien
Global Healthcare Products Leader
Specialized In: Biotechnology, Electronics, Healthcare & Medical
Acquired by: Medtronic
Business Type: Delisted
Employees: 10001+
Last Investment Activity: Jul 4, 2023
Founded Date: 2007
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:COV
Operating Status: Closed
Investor Type: Venture Capital
18 Emails
0 Phones
Main email format: sarah.smith@covidien.com (100.0%)
-
Bryan Hanson
Group President
b**********n@covidien.com
-
Christopher Swistak
c*****************k@covidien.com
-
Lyne Bessette
Contract Administrator
l***********e@covidien.com
-
Cynthia New
Territory Account Manager
c*********w@covidien.com
-
Erin Wehrly
e*********y@covidien.com
-
Matt Griffin
m*************n@covidien.com
-
Kristina Bond
Senior Hernia Specialist
k***********d@covidien.com
-
Lindsay Rodgers
l*************s@covidien.com
-
Charles Travis
Director, Field Medical Affairs Team at Ascendis Pharma A/S
c************s@covidien.com
-
Jennifer Radmer CAP-OM-TA, MOS
j*************r@covidien.com
-
Lisa French
U.S. Women's Health Business Unit Lead
l*********h@covidien.com
-
Kristi Winger Szudlo
Autoimmune and Rare Disease Specialist
k***********o@covidien.com
-
Claire Adams
c**********s@covidien.com
-
Unclassified inbox
gabreila.benitez@covidien.com
-
Unclassified inbox
gabirela.benitez@covidien.com
-
Unclassified inbox
claire.adams@covidien.com
-
Unclassified inbox
liamhynes@covidien.com
-
Unclassified inbox
anz.recalls@covidien.com
Kemin Industries
Kemin Industries provides health-related products Show more...to improve the quality, safety, and efficacy of food.
Specialized In: Biotechnology, Food Delivery
Business Type: Private
Employees: 1001-5000
Rounds: Debt Financing
Last Investment Activity: Jan 15, 2024
Founded Date: 1961
Company Type: For Profit
Operating Status: Active
14 Emails
0 Phones
Main email format: sarah.smith@kemin.com (50.0%)
-
Adriano Di Toppa
Enterprise Data Manager
a*****o@kemin.com
-
Prakash Chandra Saini
Marketing Manager
p***********i@kemin.com
-
Chris Kowald
Equipment Engineer
c**********d@kemin.com
-
Henry Fisher
h**********r@kemin.com
-
Jason Shelton
Vice President Research and Development
j***n@kemin.com
-
Mary Nelson
Founder
m*********n@kemin.com
-
Geoff Horst
R&D
g***f@kemin.com
-
Gary Hayen
Senior Vice President Business Development
gh@kemin.com
-
Sang Kuang
Chief Executive Officer
s**g@kemin.com
-
Erik Creemers
Senior Vice President Finance EMEA
e**k@kemin.com
-
Siti Imah
s*******h@kemin.com
-
Gordon Macquirter
g***************r@kemin.com
-
Unclassified inbox
haimeng.tan@kemin.com
-
Unclassified inbox
harish.methil@kemin.com
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
-
Unclassified inbox
dbriley@horizontherapeutics.com
-
Unclassified inbox
nmosdspecialistfinder@horizontherapeutics.com
-
Unclassified inbox
amilstead@horizontherapeutics.com
Tenet Healthcare Corporation
Tenet Healthcare Corporation is one of the largestShow more... investor-owned health care delivery systems in the nation.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jun 23, 2023
Founded Date: 1967
Number of Exits: 6
Company Type: For Profit
Stock Symbol: NYSE:THC
Operating Status: Active
14 Emails
0 Phones
Main email format: sarah.smith@tenethealth.com (100.0%)
-
Misha Harrell
m***********l@tenethealth.com
-
David M Sperling
d************g@tenethealth.com
-
Archie Drake
a**********e@tenethealth.com
-
Katy Mowery
k*********y@tenethealth.com
-
Takisha Lee Murray
t*********e@tenethealth.com
-
Ingrid Mcgovern
i*************n@tenethealth.com
-
Cee Cee Cuccaro
c*********o@tenethealth.com
-
Zoran Draganic
z************c@tenethealth.com
-
Jana Durfee
j*********e@tenethealth.com
-
Natalia1 Ramirez
n**************z@tenethealth.com
-
Kardy Ibanez
k**********z@tenethealth.com
-
Jennifer Coppock
j**************k@tenethealth.com
-
Unclassified inbox
dan.brothmann@tenethealth.com
-
Unclassified inbox
danbowers@tenethealth.com
DSM
DSM is a global science-based company active in heShow more...alth, nutrition and materials. By connecting its unique competences in Life Sciences.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 30, 2024
Founded Date: 1902
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCQX:RDSMY
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@thedsmgroup.com (100.0%)
-
Dimitride Vreeze
d**************e@dsm.com
-
Jos Groffils
j**********s@dsm.com
-
Enzo Trimigliozzi
e***************i@dsm.com
-
Luc Levrouw
l*********w@dsm.com
-
Verna Redington
v*************n@dsm.com
-
Jeremy Yater
j**********r@dsm.com
-
Ann Marie Pelley
a********y@dsm.com
-
Celine CARIN-CUISSINAT
c*******************t@dsm.com
-
Sara Farooq
s*********q@dsm.com
-
Adam Whitworth
a************h@dsm.com
-
Ahead-dep Reception
a*****************n@dsm.com
-
Maria-elena Rubio
m***************o@dsm.com
-
Media Relations
social.media@dsm.com
-
General Inquiries
info@dsm.com
-
Unclassified inbox
jeanet.gerritsen@dsm.com
Edwards Lifesciences
Edwards Lifesciences is a provider of science of hShow more...eart valves and hemodynamic monitoring.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Aug 19, 2024
Founded Date: Jan 1, 1958
Number of Exits: 7
Company Type: For Profit
Stock Symbol: BMV:EW
Operating Status: Active
18 Emails
1 Phones
Main email format: sarah_smith@edwards.com (100.0%)
-
Darshin Patel
Senior Manager, THV Mitral R&D
d***********l@edwards.com
-
Amanda Fowler
Vice President, Global Corporate Giving and Executive Director, Edwards Lifesciences Foundation
a***********r@edwards.com
-
Kimberley Thompson
Manager, Global Diversity, Inclusion and Belonging
k****************n@edwards.com
-
Persila Nia
Senior Quality Analyst
p*********a@edwards.com
-
Tommy Thompson
Senior Product Manager, Global Marketing
t************n@edwards.com.If
-
Parker Tyler
Director of Reliability Engineering
p**********r@edwards.com
-
Charbel Diab
Senior Director of Quality
c**********b@edwards.com
-
Nate Arnim
Senior Vice President of Worldwide Engineering
n**********m@edwards.com
-
Uday Sharan
Director Supply Chain Management
u*********n@edwards.com
-
Emmalee Nichols
Senior Specialist - Clinical Research Monitoring
e*************s@edwards.com
-
Marc Ioos
m*******s@edwards.com
-
Olgu Icoz Peng
Senior Program Manager at Thales Avionics
o*******g@edwards.com
-
General Inquiries
info@edwards.com
-
Customer Service
tech_support@edwards.com
-
Customer Service
reimbursementsupport@edwards.com
-
Unclassified inbox
mui_kiang_lim@edwards.com
-
Unclassified inbox
tech_support_uk@edwards.com
-
Unclassified inbox
demi_harris@edwards.com
Covidien
Global Healthcare Products Leader
Specialized In: Biotechnology, Electronics, Healthcare & Medical
Acquired by: Medtronic
Business Type: Delisted
Employees: 10001+
Last Investment Activity: Jul 4, 2023
Founded Date: 2007
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:COV
Operating Status: Closed
Investor Type: Venture Capital
13 Emails
0 Phones
Main email format: sarah.smith@covidien.com (100.0%)
-
Bryan Hanson
Group President
b**********n@covidien.com
-
Christopher Swistak
c*****************k@covidien.com
-
Lyne Bessette
Contract Administrator
l***********e@covidien.com
-
Cynthia New
Territory Account Manager
c*********w@covidien.com
-
Erin Wehrly
e*********y@covidien.com
-
Matt Griffin
m*************n@covidien.com
-
Kristina Bond
Senior Hernia Specialist
k***********d@covidien.com
-
Lindsay Rodgers
l*************s@covidien.com
-
Charles Travis
Director, Field Medical Affairs Team at Ascendis Pharma A/S
c************s@covidien.com
-
Jennifer Radmer CAP-OM-TA, MOS
j*************r@covidien.com
-
Lisa French
U.S. Women's Health Business Unit Lead
l*********h@covidien.com
-
Kristi Winger Szudlo
Autoimmune and Rare Disease Specialist
k***********o@covidien.com
-
Unclassified inbox
Paulgregory0000@gmail.com
Natera
Natera specializes in cell-free DNA testing to proShow more...vide a more targeted interventions to oncology, women's health, and organ health.
Specialized In: Biotechnology, Health Diagnostics, Healthcare & Medical
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 29, 2024
Founded Date: 2004
Company Type: For Profit
Stock Symbol: FRA:45E
Operating Status: Active
17 Emails
0 Phones
Main email format: ssmith@natera.com (100.0%)
-
Matthew Rabinowitz
CEO, Co-Founder & Executive Chairman
m*********z@natera.com
-
Asaf Sadowsky
Director, Product Management
a*******y@natera.com
-
Maria Querrey
Regional Director
m******y@natera.com
-
Kimberly Dumont
Clinical Oncology Specialist
k*m@natera.com
-
Kevin Maravilla
Supervisor, R&D RCLIA
k********a@natera.com
-
Olga Alexeeva
Senior Marketing Manager: Business Development and Digital
o*******a@natera.com
-
Lauren Visciano
Clinical Field Specialist
l*******o@natera.com
-
Omar Rodriguez
o********z@natera.com
-
Manuel Monge
Director, Direct to Consumer Digital Marketing & eCommerce
m****e@natera.com
-
Klaudia Baran
k****r@natera.com
-
Semeret Wolde
s****e@natera.com
-
General Inquiries
info@natera.com
-
Investor Relations
investor@natera.com
-
Unclassified inbox
gkollu@natera.com
-
Unclassified inbox
jsheena@natera.com
-
Unclassified inbox
concur@natera.com
-
Unclassified inbox
jstaiti@natera.com
Kite Pharma
Kite Pharma is a development-stage biotechnology cShow more...ompany designing and developing immune-based therapies to treat cancer indications.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Nov 30, 2023
Founded Date: 2009
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:KITE
Operating Status: Active
Investor Type: Venture Capital
16 Emails
0 Phones
Main email format: ssmith@kitepharma.com (100.0%)
-
Juliati Rahajeng
Manager, Regulatory Writing
j*******g@kitepharma.com
-
Emmanuelle Cunha
Yescarta Product Team Lead
e****a@kitepharma.com
-
Ryan Carrera
Senior Manager of Supply Chain - Enterprise Systems BPO Finance
r******a@kitepharma.com
-
Jose Lanz
Director Project Controls
j***z@kitepharma.com
-
Jorge Jr
Materials Technician
j********z@kitepharma.com
-
Brij Parikh
Sr. Manager, Validation
b*****h@kitepharma.com
-
Saomai Nguyenmau
Senior Manager, External Research Collaboration
s********u@kitepharma.com
-
Khachik Najaryan
Sr. Manager, Supply Chain
k*******n@kitepharma.com
-
Danny Lee
Cell Therapy Specialist II+
d**e@kitepharma.com
-
Jenn Taylor
Senior Talent Acquisition Specialist
j******6@kitepharma.com
-
Lynn Wondergem
IT Business Partner
l********m@kitepharma.com
-
General Inquiries
info@kitepharma.com
-
Unclassified inbox
abot@kitepharma.com
-
Unclassified inbox
rossintrossin@kitepharma.com
-
Unclassified inbox
ajusuf@kitepharma.com
-
Unclassified inbox
gbonaccorso@kitepharma.com
Cipla
Cipla is a drug manufacturing company that focusesShow more... on a variety of pharmaceutical products.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Jul 28, 2024
Founded Date: 1935
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NSE:CIPLA
Operating Status: Active
19 Emails
0 Phones
Main email format: sarah.smith@cipla.com (90.9%)
-
Yusuf Hamied
Chairman of the Board
y**********d@cipla.com
-
Narendra Choudhari
Director & Sr Marketing Head Cipla Ltd.
n****************i@cipla.com
-
Mangesh Vaze
Sr Director
m**********e@cipla.com
-
Priya Hargunani
Deputy Manager Medical Services (Oncology)
p*************i@cipla.com
-
Prathamesh Govekar
Director
p****************r@cipla.com
-
Lakshya Patil
Production Officer
l***********l@cipla.com
-
Devaughn Stephens
Head of Human Resources @ InvaGen Pharmaceuticals, Inc.
d***************s@cipla.com
-
Rathindra Das
Management Staff-Finance (Corporate Regulatory)
r***********s@cipla.com
-
Samina Vaziralli
Global Head - Strategy & New Ventures
s****a@cipla.com
-
Satyen Manikani
s*************i@cipla.com
-
Aakanksha Yadav
a*************v@cipla.com
-
General Inquiries
contactus@cipla.com
-
Unclassified inbox
Cipla.cs@cipla.com
-
General Inquiries
Contact@cipla.com
-
Unclassified inbox
drugsafety@cipla.com
-
Unclassified inbox
dlhreg@cipla.com
-
Unclassified inbox
vijay.yadav@cipla.com
-
Unclassified inbox
ibhrhub@cipla.com
-
Unclassified inbox
athrhubwest@cipla.com
CSL
CSL develops innovative biotherapies and influenzaShow more... vaccines that save lives, and help people with life-threatening medical conditions.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Apr 25, 2024
Founded Date: Jan 1, 1916
Company Type: For Profit
Stock Symbol: ASX:CSL
Operating Status: Active
17 Emails
0 Phones
Main email format: sarahs@csl.com (66.7%)
-
Joy Linton
Chief Financial Officer
j********n@csl.com
-
Elly Reilly
Office Manager & Executive Assistant to Regional Head MENA
e***r@csl.com
-
Herve Gisserot
h****g@csl.com
-
Rahul Oliver
Associate Director Quality Assurance
r**********r@csl.com
-
Josh Taylor
Owners Representative - Bulk Equipment Project Manager
j***t@csl.com
-
Paul Perreault
CEO & Managing Director, CSL Ltd.
p***p@csl.com
-
Cyntia Pietrobon
Key Account Manager
c*****p@csl.com
-
Reynir Svavar Eiríksson
r**************n@csl.com
-
Alexandra Christodoulopoulou
International Health Economics & Reimbursement Senior Manager
a**************************u@csl.com
-
Brian Dudt
b****d@csl.com
-
Marije Van Huffel
m**************l@csl.com
-
Unclassified inbox
web.queries@computershare.com.au
-
Unclassified inbox
dongyr@csl.com
-
General Inquiries
rw-info@csl.com
-
Unclassified inbox
callan@csl.com
-
Unclassified inbox
tima@csl.com
-
Unclassified inbox
sustainability@csl.com
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
18 Emails
0 Phones
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chad Cleveland
Director - Data Integrity | Global Quality & Compliance
c********d@kbibiopharma.com
-
Nicolas Fouque
Director of Manufacturing Science and Technologies - Geneva
n*****e@kbibiopharma.com
-
Allison Fallon
Talent Acquisition Specialist III
a*****n@kbibiopharma.com
-
Davinder Singh
Vice President Finance
d****h@kbibiopharma.com
-
Jeanie Lipscombe
Recruiting Specialist
j*****s@kbibiopharma.com
-
Robin Elleston
Director Of Quality Assurance
r*******n@kbibiopharma.com
-
Thomas Bellocci
Supply Chain Director
t*******i@kbibiopharma.com
-
Simon Bickley
Director Global Procurement
s******y@kbibiopharma.com
-
Chandra Kelley
Vice President, Business Development
c*****y@kbibiopharma.com
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com
-
Unclassified inbox
khurshid.iqbal@kbibiopharma.com
-
Unclassified inbox
kiqbal@kbibiopharma.com
-
Unclassified inbox
jchambless@kbibiopharma.com
-
Unclassified inbox
jrocher@kbibiopharma.com
-
Unclassified inbox
inc.bbentley@kbibiopharma.com
ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group comShow more...pany, develops and markets medical devices and software solutions.
Specialized In: Biotechnology, Fitness, Healthcare & Medical, Technology & Software
Acquired by: Asahi Kasei
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Mar 20, 2023
Founded Date: 1980
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
15 Emails
0 Phones
Main email format: ssmith@zoll.com (77.8%)
-
Salman Sher
Clinical Evidence Director
s*********r@zoll.com
-
Hal Harmon
Vice President of Global Operations
h*****n@zoll.com
-
Katie Gaines
Field Sales Trainer
k*****s@zoll.com
-
Catherine Cavanaugh
Senior Talent Acquisition Partner
c********h@zoll.com
-
Jodi Cipriano
Vice President Human Resources
j*******o@zoll.com
-
Marco Piccolboni
agente
m*********i@zoll.com
-
Wendy Diedrich
Senior International Account Manager at ZOLL Medical Corporation
w*******h@zoll.com
-
Elena Ivanova
Manager, Clinical Data Management
e******a@zoll.com
-
Raeshell Weir, CPA, CGA
Senior Accounting and Operations Manager
r***r@zoll.com
-
Christopher L Swenglish
c********h@zoll.com
-
Landon Perdue
l***********e@zoll.com
-
General Inquiries
info@zoll.com
-
Unclassified inbox
webmaster@zoll.com
-
Unclassified inbox
acreen@zoll.com
-
Unclassified inbox
tgagliardi@zoll.com
Albany Molecular Research
“Albany Molecular Research Inc. provides scientifiShow more...c services, products and technologies that improve quality of life while delivering
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@amriglobal.com (100.0%)
-
Andrew Boze
Research Scientist I
a*********e@amriglobal.com
-
Steven Pawlows
Senior Manager
s************s@amriglobal.com
-
Susan Billings
Vice President & Global Head of Business Development
s************s@amriglobal.com
-
Griffin White
g***********e@amriglobal.com
-
Ikia Pwalther
Senior Director Business Development
i***********r@amriglobal.com
-
Tim Tuegel
t********l@amriglobal.com
-
Michael Haswell
m*************l@amriglobal.com
-
Shane Brown
s*********n@amriglobal.com
-
Debasis Patra
d***********a@amriglobal.com
-
Anandasekar Rangsamy
a******************y@amriglobal.com
-
Cheryl Movsesian
c**************n@amriglobal.com
-
General Inquiries
InvestorInfo@amriglobal.com
-
Unclassified inbox
patty.eisenhaur@amriglobal.com
-
Unclassified inbox
seena.sankar@amriglobal.com
-
Unclassified inbox
matthew.isherwood@amriglobal.com
-
Unclassified inbox
pamela.goh@amriglobal.com
nference
nference is a software company that creates transfShow more...ormative technologies and products in healthcare.
Specialized In: Biotechnology, Healthcare & Medical, Technology & Software
Business Type: Private
Employees: 251-500
Rounds: Non-equity Assistance
Last Investment Activity: Dec 5, 2023
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah@nference.com (80.0%)
-
Dibakar Saha
Data Engineer
d*****r@nference.com
-
Vaibhav Dalal
v***********l@nference.com
-
Murali Aravamudan
Co-Founder & Chief Executive Officer
m****i@nference.com
-
Will Gibson
Scientific Consultant
w**l@nference.com
-
Karthik Murugadoss
Senior Data Scientist
k*****k@nference.com
-
Arjun Puranik
Head of Math & Statistics
a***n@nference.com
-
Hutch Fishman
CFO
h***h@nference.com
-
Balaraman Lakshmanan
Senior Engineering Manager
b*******n@nference.com
-
Agustin Lopez Marquez
VP Business Development & Marketing
a***************z@nference.com
-
Vab Goel
Investor
v*b@nference.com
-
General Inquiries
info@nference.com
-
Admin Team
admin@nference.com
-
Customer Service
support@nference.com
-
Sales Department
sales@nference.com
-
General Inquiries
help@nference.com
-
General Inquiries
info@nference.net
-
Unclassified inbox
responsible-disclosure@nference.com
Sartorius
Sartorius helps its customers to develop and manufShow more...acture biotech medicines reliably, quickly, and economically.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@sartorius.com (100.0%)
-
Joachim Kreuzburg
Chairman of the Executive Board and CEO
j***************g@sartorius.com
-
Mareva Gueneron
Head Of Project Management Office (PMO)
m*************n@sartorius.com
-
Floris Smet
Manager - Process Development Consultants
f***********t@sartorius.com
-
Jeannine Hillmer
Field Account Manager
j**************r@sartorius.com
-
Sven Wagner
Head of Business Development
s*********r@sartorius.com
-
Vincent Galione
Digital Account Manager - Southeast
v*************e@sartorius.com
-
Dominik Kopp
Manager IT Service Framework
d**********p@sartorius.com
-
Jeanette Minshall
j***************l@sartorius.com
-
Jens Matuszczyk
j*************k@sartorius.com
-
Katrin Toeppner
k*************r@sartorius.com
-
General Inquiries
info@sartorius.com
-
Admin Team
admin@sartorius.com
-
General Inquiries
info@sartorius-stedim.com
-
Unclassified inbox
info.austria@sartorius.com
-
Unclassified inbox
guido.schmidbauer@sartorius.com
Sorrento Therapeutics
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
17 Emails
0 Phones
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Yan Li
Senior Scientist, Antibody Technology Development
y*i@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Vanessa Mendez
Quality
v*****z@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Dindo Sy Chu
Vice President Finance
d**u@sorrentotherapeutics.com
-
Hua Huang
Director
h****g@sorrentotherapeutics.com
-
Mark Brunswick
SVP Head of Regulatory Affairs and Quality
m********k@sorrentotherapeutics.com
-
Silvia Chang
Head of Small Molecule Program Management/Executive Director Program Management
s****g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com
-
Unclassified inbox
investoren@sorrentotherapeutics.com
-
Unclassified inbox
doanh@sorrentotherapeutics.com
-
Unclassified inbox
investisseurs@sorrentotherapeutics.com
Allergan
Allergan is a global pharmaceutical company.
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals, Universities & Colleges
Acquired by: AbbVie
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 13, 2024
Founded Date: 1948
Company Type: For Profit
Stock Symbol: NYSE:AGN
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@allergan.com (100.0%)
-
Natalie Anderten
Director, Clinical Development Operations
c************e@allergan.com
-
Lou Foytik
Associate Director, Contract Account Management
f********u@allergan.com
-
Vicky Yuan
Pr. Statistical SAS Programmer
y********y@allergan.com
-
Delaney Ahern
Brand Marketing, BOTOX® Cosmetic
a***********y@allergan.com
-
Viresh Thakerar
International External Innovation Lead
t*************h@allergan.com
-
Jamie Weidle
Senior Business Development Manager
w**********e@allergan.com
-
George Saltzberg
s**************e@allergan.com
-
Sharon DeFeo
d**********n@allergan.com
-
Quality Switzerland
q*****************d@allergan.com
-
Marcy Schwoegler
m**************r@allergan.com
-
Investor Relations
edith.auclair@allergan.com
-
Unclassified inbox
mora_yolanda@allergan.com
-
Unclassified inbox
me-serv_clientes@allergan.com
Bio-Techne
Bio-Techne is a supplier of tools for life scienceShow more... research, therapeutic manufacturing, and clinical diagnostics.
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 7, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:TECH
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@bio-techne.com (100.0%)
-
Dawn Gast
Site Director, San Marcos
d*******t@bio-techne.com
-
Charles Kummeth
President and CEO
c*************h@bio-techne.com
-
Chrysteven Flores
Technician
c***************s@bio-techne.com
-
John Syverud
Sr. Director, Commercial Development and Custom Services
j**********d@bio-techne.com
-
Adriana Morales
Senior Global Marketing Manager Strategist
a*************s@bio-techne.com
-
Marty Putnam
CTO, Analytical Solutions Division
m**********m@bio-techne.com
-
Paul Joseph
Cell & Gene Therapy Business Development Manager
p*********h@bio-techne.com
-
Brian Haynes
b**********s@bio-techne.com
-
Aimee Rogers
a**********s@bio-techne.com
-
Andrew Wilcox
a***********x@bio-techne.com
-
General Inquiries
techinfo@techne-corp.com
-
Unclassified inbox
jhippel@bio-techne.com
-
General Inquiries
info@bio-techne.com
Seattle Children’s
Seattle Children’s is a Non-profit organisation.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Travel & Hospitality
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: May 29, 2024
Founded Date: 1907
Company Type: Non-profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@seattlechildrens.org (100.0%)
-
Suzanne Seo
s*********o@seattlechildrens.org
-
Vittorio Gallo
v************o@seattlechildrens.org
-
Gabrielle Douthitt
g**************l@seattlechildrens.org
-
Emily Beauchemin
e**************n@seattlechildrens.org
-
Shannon Oda
s*********a@seattlechildrens.org
-
Nicole Ardres
n***********s@seattlechildrens.org
-
Jason S. Hauptman MD PhD
j*********s@seattlechildrens.org
-
Therese Mirisola
t**************a@seattlechildrens.org
-
Maria Brnjic
m**********c@seattlechildrens.org
-
Gina Sadowski
g***********i@seattlechildrens.org
-
Unclassified inbox
askus@seattlechildrens.org
Bavarian Nordic
Bavarian Nordic is a industrial biotechnology compShow more...any developing and producing novel vaccines for the treatment and prevention.
Specialized In: Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Dec 22, 2023
Founded Date: 1994
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCPINK:BVNRY
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@bavarian-nordic.com (87.5%)
-
Paul Chaplin
Executive Vice President & CSO
p**********n@bavarian-nordic.com
-
Henning Juul
Operatør
h**********l@bavarian-nordic.com
-
Li Westerlund
Vice President Global IP
l***********d@bavarian-nordic.com
-
Thomas Duschek
Communications Specialist
t************k@bavarian-nordic.com
-
Iben Bachner
Receptionist
i**********r@bavarian-nordic.com
-
Asger Aamund
chairman
a**********d@bavarian-nordic.com
-
Mark Clarke
Digital Marketing Manager, US
m**k@bavarian-nordic.com
-
Anu Helena Kerns
EVP, Chief People and Organization
a*******s@bavarian-nordic.com
-
Sofie Brogaard
s************d@bavarian-nordic.com
-
General Inquiries
info@bavarian-nordic.com
-
Unclassified inbox
uwe.werner@bavarian-nordic.com
-
Unclassified inbox
lich@bavarian-nordic.com
-
Unclassified inbox
lmu@bavarian-nordic.com
Ferring
Ferring is a biopharmaceutical company that develoShow more...ps reproductive medicine for healthacare sectors.
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Debt Financing
Last Investment Activity: Jan 16, 2024
Founded Date: 1950
Company Type: For Profit
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@ferring.com (100.0%)
-
Casper Johansen
Director Business Development, Search & Evaluation
c*************n@ferring.com
-
Emilia Brusco
HR Director, South America
e***********o@ferring.com
-
Elda Dinaj
Global Strategic Brand Leader, Gastroenterology & Endocrinology
e********j@ferring.com
-
Camilla Munksgaard
Associate Director, HR
c****************d@ferring.com
-
Brent Ragans
President, Ferring Pharmaceuticals U.S.
b**********s@ferring.com
-
Phil Hanfling
Manager, Site Contracts
p***********g@ferring.com
-
Anie Azroyan, PhD, MBA
a**********n@ferring.com
-
Safety Indiamailbox
s*****************x@ferring.com
-
Jobs India
j********a@ferring.com
-
General Inquiries
info@ferring.com
-
Admin Team
admin@ferring.com
-
Investor Relations
investor@ferring.com
-
General Inquiries
contact@ferring.com
-
Sales Department
sales@ferring.com
-
Unclassified inbox
ecs@ferring.com
-
Unclassified inbox
nicholas.borgia@ferring.com
-
Unclassified inbox
l@ferring.com
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Christina Agapakis
Creative Director
c*******a@ginkgobioworks.com
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
Zachary King
Director Of Marketing Operations
z**********g@ginkgobioworks.com
-
Jhonny Martinez
Facilities Technician
j*************z@ginkgobioworks.com
-
Sean Leblanc
Senior Director of Foundry Operations
s**n@ginkgobioworks.com
-
Yaoyu Yang
Principal Software Engineer
y***u@ginkgobioworks.com
-
Tomek Brzezinski
Automation Engineer
t***k@ginkgobioworks.com
-
Soon Gang Choi
Senior Test Engineer
s**n@ginkgobioworks.com
-
Ian Meyer
Associate Director, Strategic Finance
i*n@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com
-
Investor Relations
20investors@ginkgobioworks.com
-
General Press Inquiries
20press@ginkgobioworks.com
-
Unclassified inbox
jason@ginkgobioworks.com
-
Unclassified inbox
curt@ginkgobioworks.com
-
Unclassified inbox
aailloni@ginkgobioworks.com
Integra LifeSciences
Integra LifeSciences is an integrated medical deviShow more...ce company.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 11, 2024
Founded Date: 1989
Company Type: For Profit
Stock Symbol: NASDAQ:IART
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@integralife.com (100.0%)
-
Stuart Essig
Chairman of the Board
s**********g@integralife.com
-
Chiara Vieceli
EMEA Marketing Manager Tissue Technologies
c************i@integralife.com
-
Allison Bedwinek
Staff Engineer, Research & Development
a************r@integralife.com
-
Sarah Mawhinney
Marketing Operations Associate
s*************y@integralife.com
-
Charles Ciaburri
Analyst, Sales Incentive Compensation
c**************i@integralife.com
-
Brent Hancock
Manager - Regenerative Business Leaders
b***********k@integralife.com
-
Damien Rhodes
Account Manager
d***********s@integralife.com
-
Kain C
Surgical Sales Representative
k****c@integralife.com
-
Mayna Muenchow
m************w@integralife.com
-
General Inquiries
info@integralife.com
-
Customer Service
support@integralife.com
-
Sales Department
sales@integralife.com
-
General Inquiries
feedback@integralife.com
-
Unclassified inbox
custsvcnj@integralife.com
-
Unclassified inbox
eu.remittance@integralife.com
-
Unclassified inbox
tim.mikac@integralife.com
-
Unclassified inbox
adminmicrofrance@integralife.com
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
15 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
-
Unclassified inbox
careers@loxooncology.com
-
Unclassified inbox
jake@loxooncology.com
-
Unclassified inbox
bschmitz@loxooncology.com
-
Unclassified inbox
cbethune@loxooncology.com
Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is an integrated pharmaceShow more...utical company committed to accelerating access to affordable & innovative medicines.
Specialized In: Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: May 29, 2024
Founded Date: Feb 24, 1984
Company Type: For Profit
Stock Symbol: FRA:RDDA
Operating Status: Active
19 Emails
0 Phones
Main email format: sarahsmith@drreddys.com (50.0%)
-
Marc Kikuchi
Chief Executive Officer
m******i@drreddys.com
-
Vivek Mittal
v*********l@drreddys.com
-
Satish Reddy
s****h@drreddys.com
-
Raghavendar D
r**********d@drreddys.com
-
Archis Joshi
a*********i@drreddys.com
-
Adiba Ahmed
a********d@drreddys.com
-
Huzaifa Basrai
h***********i@drreddys.com
-
Lalatendu Panigrahi
l********p@drreddys.com
-
Mohammad Safi Shalamzari
m*******s@drreddys.com
-
Customer Service
customerservices@drreddys.com
-
Unclassified inbox
dataprivacy@drreddys.com
-
Unclassified inbox
api@drreddys.com
-
Unclassified inbox
shares@drreddys.com
-
Media Relations
socialmedia@drreddys.com
-
Unclassified inbox
kkonala@drreddys.com
-
Unclassified inbox
vasup@drreddys.com
-
Unclassified inbox
aprabhusanthosh@drreddys.com
-
Unclassified inbox
richaperiwal@drreddys.com
-
Unclassified inbox
farmacovigilanca@drreddys.com
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
11 Emails
0 Phones
Main email format: sarah.smith@genzyme.com (100.0%)
-
Helene Nagy
Label Development Manager, Clinical Supplies
h*********y@genzyme.com
-
Patti Nardi
Head of Global Product Supply Chain
p*********i@genzyme.com
-
Philippe Mazars
Quality Control Associate Director
p*************s@genzyme.com
-
Bryan Gillis
b**********s@genzyme.com
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
l***********y@genzyme.com
-
Richard Garman
r************n@genzyme.com
-
Mary Chabot
m*********t@genzyme.com
-
Unclassified inbox
carlos.figueroachamorro@genzyme.com
-
Unclassified inbox
nic.grund@genzyme.com
Horizon Discovery
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Kevin Koker
Customer Service Manager
k*********r@horizondiscovery.com
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Natalie Cowan
Business Development Manager
n***********n@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
Jeffrey Dale
Business Development Manager, Midwest (South), Products and Services (including In Vivo)
j**********e@horizondiscovery.com
-
Abhay Joshi
Business Development Manager
a*********i@horizondiscovery.com
-
Hadas Raveh-Amit
Senior Scientist
h*************t@horizondiscovery.com
-
Andrea Frapporti
a**************i@horizondiscovery.com
-
U003eandrea Frapporti
u*******************i@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com
-
Unclassified inbox
j.moore@horizondiscovery.com
-
Unclassified inbox
darrin.disley@horizondiscovery.com
-
Unclassified inbox
noreply@horizondiscovery.com
NuVasive
NuVasive is a medical device company that creates Show more...minimally invasive surgical products and procedurally integrated spine solutions.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Acquired by: Globus Medical
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 16, 2024
Founded Date: Jan 1, 1997
Company Type: For Profit
Stock Symbol: NASDAQ:NUVA
Operating Status: Active
19 Emails
2 Phones
Main email format: ssmith@nuvasive.com (100.0%)
-
Ryan Hurt
Enabling Technologies Manager
r***t@nuvasive.com
-
Johnny Chen
Sr Program Manager
j***n@nuvasive.com
-
Ryan Donahoe
Chief Technology Officer
e********z@nuvasive.com
************9
-
Ryan Donahoe
Chief Technology Officer
j******n@nuvasive.com
-
Peter Marzano
Vice President Commercial, EMEA
p******o@nuvasive.com
-
Paul Peralta
Systems/Database Administrator, IT Infrastructure
p******a@nuvasive.com
-
Christine Martin
Sr. Manager, Strategy & Corporate Development
c*****n@nuvasive.com
-
Ejehan Turker
Director of Global Compliance
e*****r@nuvasive.com
-
Brian Adashek
Senior Manager, Global Business Ethics and Compliance
b******k@nuvasive.com
-
Unclassified inbox
ncspatientcare@nuvasive.com
-
Unclassified inbox
NSF@nuvasive.com
-
Unclassified inbox
abcdefghij@nuvasive.com
-
Unclassified inbox
privacy@nuvasive.com
-
General Inquiries
info@nuvasive.com
-
Unclassified inbox
mdegraw@nuvasive.com
-
Unclassified inbox
jhannon@nuvasive.com
-
Unclassified inbox
mburns@nuvasive.com
-
Unclassified inbox
ypeng@nuvasive.com
-
Unclassified inbox
servizioclienti@nuvasive.com
Novozymes
Novozymes is the world leader in bioinnovation.
Specialized In: Biotechnology, Energy & Utilities
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jul 22, 2024
Founded Date: 2000
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:NZYM-B
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah@novozymes.com (40.0%)
-
Jan Danielsen)
Senior Reseach Associate
j**a@novozymes.com
-
Ester Baiget
President & CEO
e***r@novozymes.com
-
Claus Fuglsang
Vice President, BioEnergy R&D
c*f@novozymes.com
-
Henry Xiang
Chairman
x***g@novozymes.com
-
Merete Møller Engelsen
Industry Technology Specialist, TS Baking Europe
m**n@novozymes.com
-
Rasmus Steen Mortensen
Vice President, Leadership and Organization
r**o@novozymes.com
-
Elisa Pasch
Senior Integration Program Manager, Commercial Integration
e****p@novozymes.com
-
Louise Lihn
Head of Business Unit, Global Marketing, Consumer Biosolutions
l*****l@novozymes.com
-
Annelise Vidø
a******e@novozymes.com
-
Unclassified inbox
swm@novozymes.com
-
Unclassified inbox
lla@novozymes.com
-
Unclassified inbox
gskr@novozymes.com
-
Unclassified inbox
20hlhv@novozymes.com
-
Unclassified inbox
hlhv@novozymes.com
-
Unclassified inbox
yuhb@novozymes.com
bioMerieux
bioMérieux develops and produces in vitro diagnostShow more...ic solutions for private and hospital laboratories, mainly for the diagnosis.
Specialized In: Biotechnology, Health Diagnostics, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Last Investment Activity: Sep 5, 2024
Founded Date: 1963
Number of Exits: 3
Company Type: For Profit
Stock Symbol: EPA:BIM
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@biomerieux.com (100.0%)
-
Matthew Canavan
m*************n@biomerieux.com
-
Mathilde Chabanis
m***************s@biomerieux.com
-
Laurent Abenza
Responsable RH Site
l************a@biomerieux.com
-
Vikrant Dutta
v***********a@biomerieux.com
-
Morgane Terres
m************s@biomerieux.com
-
Marc Haribou
m**********u@biomerieux.com
-
Arnaud FAVRY
Patient value strategy and public & governmental affairs manager at bioMérieux
a**********y@biomerieux.com
-
Ewelina Wieczorek
e***************k@biomerieux.com
-
Fanny Poujol
f**********l@biomerieux.com
-
General Inquiries
info@biomerieux.com
-
Admin Team
admin@biomerieux.com
-
Customer Service
support@biomerieux.com
-
Unclassified inbox
mary.licavoli@biomerieux.com
-
Unclassified inbox
adrien.prevosto@biomerieux.com
-
Human Resources Team
bmk.hr@biomerieux.com
Indivior
Indivior is a specialty pharmaceuticals business.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 21, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:INDV
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@indivior.com (100.0%)
-
Cathy Thomas
National Sales Manager
c**********s@indivior.com
-
Jennie Witherspoon
Sr. Clinical Specialist
j****************n@indivior.com
-
Diana Minervini
Channel/Trade Accounts
d*************i@indivior.com
-
Sincear Fountain
Regional Account Director
s**************n@indivior.com
-
Naomi Guinness
UK & Ireland Talent Acquisition Specialist (VIA Korn Ferry RPO)
n************s@indivior.com
-
Steve Johnson
Senior Area Sales Manager - Behavioral Health
s***********n@indivior.com
-
Rob Vinson
Specialty Sales Consultant|Injectables Buy and Bill|Product Launches
r********n@indivior.com
-
Fred Jumper
f*********r@indivior.com
-
Lynn Taylor
l*********r@indivior.com
-
Unclassified inbox
Tom.Corran@indivior.com
-
Unclassified inbox
patientsafetyfrance@indivior.com
-
Unclassified inbox
patientsafetyna@indivior.com
-
Unclassified inbox
trialdisclosure@indivior.com
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Oralcare Maroc
o************c@pierre-fabre.com
-
Services Canada
s*************a@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
-
Unclassified inbox
ultan.power@pierre-fabre.com
-
Unclassified inbox
marie.bernadette.assie@pierre-fabre.com
-
Unclassified inbox
oralcare.maroc@pierre-fabre.com
-
Unclassified inbox
services.canada@pierre-fabre.com
-
Unclassified inbox
oncology.nl@pierre-fabre.com
Purdue Pharma
Purdue Pharma develops, manufactures, and markets Show more...medications and consumer health products.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Dec 4, 2023
Founded Date: 1892
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@purduepharma.com (62.5%)
-
Cherilyn Calia
Business Analyst
c************a@purduepharma.com
-
Bill Watson
w****n@purduepharma.com
-
Heather Jordan
Industry Account Executive at SAP
j****n@purduepharma.com
-
Stephen Rayda
Global Head of Infrastructure and Client Services at Purdue Pharma L.P.
s***********a@purduepharma.com
-
Donna Krizik
Experienced Marketing Director | SEO | B2B Marketer | Content Strategist
dk@purduepharma.com
-
Marc Kesselman
S.V.P. & General Counsel
m************n@purduepharma.com
-
Stuart Baker
s**********r@purduepharma.com
-
Stuartd Baker
s***********r@purduepharma.com
-
General Inquiries
purduemedInfo@pharma.com
-
Unclassified inbox
ann.kraft@purduepharma.com
-
Unclassified inbox
brianne.weingarten@purduepharma.com
inVentiv Health
inVentiv Health offers clinical and commercial proShow more...fessional services to help biopharmaceutical companies streamline their processes.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Jan 11, 2018
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Operating Status: Closed
12 Emails
0 Phones
Main email format: sarah.smith@inventivhealth.com (100.0%)
-
Yuet Mei Han
IT Senior Analyst
y******n@inventivhealth.com
-
Jim Owers
Director, Digital Strategy and Head of Digital Production
j*******s@inventivhealth.com
-
Ann-Marie Terry
Clinical Research Associate II
a************y@inventivhealth.com
-
Latrell Rivers
l************s@inventivhealth.com
-
Vaibhav Divekar
Senior CDM
v*************r@inventivhealth.com
-
Martin Prosser
Senior Business Development Director
m************r@inventivhealth.com
-
Thomas Carlo Maria Topini
t***********i@inventivhealth.com
-
Yuliia Bahatska
y*************a@inventivhealth.com
-
Unclassified inbox
bruce.crawford@inventivhealth.com
-
Unclassified inbox
michael.estes@inventivhealth.com
-
Unclassified inbox
cannesdo@inventivhealth.com
-
Unclassified inbox
ncannesdo@inventivhealth.com
Guardant Health
Guardant Health is a precision oncology company thShow more...at uses blood tests, data sets, and analytics to provide treatment to cancer patients.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 6, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:GH
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@guardanthealth.com (100.0%)
-
Amirali Talasaz
Co-founder, President and Chairman
a******z@guardanthealth.com
-
Clancy Smith
Senior Recruiter
c****h@guardanthealth.com
-
Rafael Silva
Account Manager
r****a@guardanthealth.com
-
Soni Shukla
Head of Oncology Product Development- Global
s*****a@guardanthealth.com
-
Meredith Montgomery
Account Executive
m*********y@guardanthealth.com
-
Monique Brausa
Account Executive
m*****a@guardanthealth.com
-
Mehran Entezari
Head Of Information Technology
m@guardanthealth.com
-
Sucharita Nandan
s*****n@guardanthealth.com
-
General Press Inquiries
press@guardanthealth.com
-
Unclassified inbox
ifaull@guardanthealth.com
-
Unclassified inbox
egaudens@guardanthealth.com
-
Unclassified inbox
getscreened@guardanthealth.com
-
Unclassified inbox
patientadvocacy@guardanthealth.com
Magellan Health Services
Magellan Health Services is a healthcare managemenShow more...t organization that focuses on managing behavioral healthcare and diagnostic imaging.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Acquired by: Evolent Health
Business Type: Public
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Mar 23, 2023
Founded Date: 1969
Company Type: For Profit
Stock Symbol: NASDAQ:MGLN
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@magellanhealth.com (66.7%)
-
Yagnesh Vadgama
y******a@magellanhealth.com
-
Celeste Lippy
VP, Clinical Operations
c****y@magellanhealth.com
-
Deena Feinstein Krulewitz
d********z@magellanhealth.com
-
Alisa Bahl
b***a@magellanhealth.com
-
Sam Srivastava
s*********a@magellanhealth.com
-
Richard Buccigross
Associate Medical Director
r*********s@magellanhealth.com
-
Ramela Dadayan
d******r@magellanhealth.com
-
Gail Fowler
g******r@magellanhealth.com
-
Sales Department
BHSales@MagellanHealth.com
-
Unclassified inbox
agirgenti@magellanhealth.com
-
Unclassified inbox
scjameson@magellanhealth.com
-
Unclassified inbox
mjsammanasuvincent@magellanhealth.com
-
Unclassified inbox
anwilliams1@magellanhealth.com
-
Unclassified inbox
kathleenjimenez@magellanhealth.com
Cytokinetics
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
16 Emails
0 Phones
Main email format: ssmith@cytokinetics.com (100.0%)
-
Robert Blum
President & CEO
r***m@cytokinetics.com
-
Kymberly Hernandez
HR Director, Commercial and Medical Affairs
k********z@cytokinetics.com
-
Dean Reid
d***d@cytokinetics.com
-
Regina Sohn
Medical Director
r***n@cytokinetics.com
-
Tina Controy
t******y@cytokinetics.com
-
Ronald Vale
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator
r***e@cytokinetics.com
-
Eric Terhaerdt
Senior Vice President, Development Operations
e********t@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com
-
Unclassified inbox
compliance@cytokinetics.com
-
Unclassified inbox
jtrautman@cytokinetics.com
-
Unclassified inbox
sbarbari@cytokinetics.com
-
Unclassified inbox
mpugsley@cytokinetics.com
-
Unclassified inbox
medicalinformation@cytokinetics.com
Mirati Therapeutics
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Jing He
Associate Director Biostatistics
j*e@mirati.com
-
Maggie Ryan Laughlin
Human Resources Director, Human Resources Business Partner
l*******m@mirati.com
-
Roch Switlik
Head Of Supply Chain Management
r**h@mirati.com
-
Stephen K Lee
Associate Director
l**s@mirati.com
-
Augustine Bourne
a*****e@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com
-
Unclassified inbox
marounc@mirati.com
-
Unclassified inbox
christensenj@mirati.com
-
Unclassified inbox
clemasters@mirati.com
-
Unclassified inbox
lemastersc@mirati.com
-
Unclassified inbox
heldn@mirati.com
NeoGenomics
NeoGenomics is a cancer reference laboratory that Show more...provides cancer testing and partnership programs to pathologists and oncologists.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@neogenomics.com (60.0%)
-
Ryan J Angell
Vice President, Oncology Services and Laboratory Collaborations
r*****l@neogenomics.com
-
David S Brooks
Divisional Vice President, Informatics
d*****s@neogenomics.com
-
Ricky Kleinsmith
Associate Director of Quality Management Systems
r*********h@neogenomics.com
-
Lakshmi Chandramohan
Principal Scientist, Associate Director, Molecular Assay Services
l***********n@neogenomics.com
-
Sharon Kaufman
s************n@neogenomics.com
-
First Last
f********t@neogenomics.com
-
Kendra Sweeney
k************y@neogenomics.com
-
Unclassified inbox
aimee.bui@neogenomics.com
-
Human Resources Team
HR@neogenomics.com
-
Human Resources Team
hr@neogenomics.com
-
Unclassified inbox
sjones@neogenomics.com
-
Unclassified inbox
sagersborg@neogenomics.com
Syneos Health
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Sean Wallace
Clinical Technician
s**********e@syneoshealth.com
-
Elgin C Duckery
District Sales Manager
e***********y@syneoshealth.com
-
Aparna Sree
Talent Acquisition Spec II
a******p@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Anita Burroughs
a*************s@syneoshealth.com
-
Susanna Giorgi
s************i@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com
-
Unclassified inbox
corporatehumanresources@syneoshealth.com
-
General Inquiries
info@syneoshealth.com
-
Unclassified inbox
xxxx@syneoshealth.com
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company thShow more...at engages in the discovery, development and commercialization of small-molecule drugs.
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 19, 2024
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:PTCT
Operating Status: Active
16 Emails
0 Phones
Main email format: ssmith@ptcbio.com (66.7%)
-
Peter P. Giannousis
Vice President Technical Operations
p*********s@ptcbio.com
-
Paul Cosenza
Associate Director Global Commercial Learning
p******a@ptcbio.com
-
Lynne Messner
Market Development Manager -- Gene Therapy
l******r@ptcbio.com
-
Brett Billmeyer
Associate Director, U.S. Patient Engagement
b********r@ptcbio.com
-
Tasha Alex
Manager, Clinical Supplies Planning
t***x@ptcbio.com
-
Neha Shah
Associate Director Quality Assurance
n*******h@ptcbio.com
-
Ludovic Baillon
Investment Analyst
l************n@ptcbio.com
-
General Inquiries
info@ptcbio.com
-
Unclassified inbox
Info.Nordic@ptcbio.com
-
Unclassified inbox
pharmacovigilance@ptcbio.com
-
General Inquiries
usmedinfo@ptcbio.com
-
Unclassified inbox
wbaird@ptcbio.com
-
Unclassified inbox
jbreslin@ptcbio.com
-
Unclassified inbox
nkkempf@ptcbio.com
-
Unclassified inbox
nma@ptcbio.com
-
Unclassified inbox
schagovets@ptcbio.com
Qiagen
QIAGEN provides technologies and products for preaShow more...nalytical sample preparation and linked molecular assay solutions.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 25, 2024
Founded Date: 1986
Number of Exits: 6
Company Type: For Profit
Stock Symbol: NYSE:QGEN
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@qiagen.com (100.0%)
-
Thierry Bernard
t*************d@qiagen.com
-
Akeeth Pinto
a**********o@qiagen.com
-
Angela Cacioppo
a*************o@qiagen.com
-
Linda Betroune
l************e@qiagen.com
-
Shilpi Purswani Vyas
s***************i@qiagen.com
-
Daniela Eltrop
d************p@qiagen.com
-
Lisa Mannagottera
l***************a@qiagen.com
-
Human Resources Team
india-hr@qiagen.com
-
Unclassified inbox
pr@qiagen.com
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Mar 4, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
15 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
-
Unclassified inbox
cgndk@alk-abello.com
-
Unclassified inbox
domingo.barber@alk-abello.com
-
Unclassified inbox
drugsafetyuk@alk-abello.com
-
Unclassified inbox
ameno@alk-abello.com
-
Unclassified inbox
infouk@alk-abello.com
Tecan
Tecan is a global provider of automated laboratoryShow more... instruments and solutions.
Specialized In: Biotechnology
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Jun 26, 2024
Founded Date: 1980
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:TECN
Operating Status: Active
13 Emails
0 Phones
Main email format: sarah.smith@tecan.com (100.0%)
-
Walter Magerl
Head Product Support, Detection
w***********l@tecan.com
-
Joerg Landig
Service Manager D A CH
j**********g@tecan.com
-
Eugen Ivanov
Project Manager Business Application Security (SAP)
e**********v@tecan.com
-
Helen Leupold
Vice President, Human Resources - Americas
h***********d@tecan.com
-
Guenter Weisshaar
g***************r@tecan.com
-
Roger Frei
r********i@tecan.com
-
Benjamin Peltier
b**************r@tecan.com
-
General Inquiries
info@tecan.com
-
Unclassified inbox
info-sg@tecan.com
-
Unclassified inbox
Judith.Stieff@tecan.com
-
Unclassified inbox
gretchen.williams@tecan.com
-
Unclassified inbox
symposium@tecan.com
-
Unclassified inbox
info-dk@tecan.com
West Pharmaceutical Services
West Pharmaceutical Services is a manufacturer of Show more...technologically advanced containment and delivery systems for injectable medicines.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jun 21, 2024
Founded Date: 1923
Company Type: For Profit
Stock Symbol: NYSE:WST
Operating Status: Active
14 Emails
0 Phones
Main email format: sarah.smith@westpharma.com (100.0%)
-
Rick Phelan
Information Technology, Sr. Director
r*********n@westpharma.com
-
Theodore Weir
Med Device & Pharma Program Manager
t***********r@westpharma.com
-
Séamus Kilbane
s************e@westpharma.com
-
Atul Patel
Vice President, Devices & Delivery Systems
a********l@westpharma.com
-
Preety Lall
p*********l@westpharma.com
-
Delphine Vanacker
d***************r@westpharma.com
-
Graham Sattler
g************r@westpharma.com
-
Unclassified inbox
John.Sweeney@westpharma.com
-
Unclassified inbox
lynn.lundy@westpharma.com
-
Unclassified inbox
Kimberly.MacKay@westpharma.com
-
Customer Service
westpharmaceuticalservices@westpharma.com
-
Unclassified inbox
hr.singapore@westpharma.com
-
Unclassified inbox
yap.kengsiang@westpharma.com
-
Unclassified inbox
safetysystems@westpharma.com
UPMC
UPMC is one of the leading nonprofit health systemShow more...s in the United States. A $10 billion integrated global health enterprise headquartered
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 29, 2024
Founded Date: 1893
Number of Exits: 10
Company Type: For Profit
Operating Status: Active
Investor Type: University Program
7 Emails
0 Phones
Main email format: sarah.smith@upmc.com (57.1%)
-
Paul Hanlon
Exec Director, Quality & Risk Management
p*********n@upmc.com
-
Erin Ragan
Staff Registered Nurse
e********n@upmc.com
-
Anna Mamo
Business Development Analyst
a**a@upmc.com
-
Reimi Vrabel
Project Coordinator
r**********l@upmc.com
-
Shunqiao Huang
s************g@upmc.com
-
James Bauersmith
Vice President
j***s@upmc.com
-
Tyler Crawford
Manager - Investments & Transactions, Strategic Finance
tyler@upmc.com
-
General Inquiries
info@upmc.com
Alkermes
Alkermes is a biotechnology company that develops,Show more... manufactures and commercializes medicines for the treatment of chronic diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 22, 2024
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ALKS
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alkermes.com (100.0%)
-
Anne Tremmel
Hospital Business Manager
a**********l@alkermes.com
-
Patricia Hedrick
Senior Production Planner
p**************k@alkermes.com
-
Robin Kleiman
Vice President, CNS Biology
r***********n@alkermes.com
-
Leah Goodnight
Director, Thought Leader Engagement
l************t@alkermes.com
-
Patrick Laclair
Director, Commercial Contract Operations
p*************r@alkermes.com
-
Ingo Mugge
i********e@alkermes.com
-
Julie Graham
j**********m@alkermes.com
-
Unclassified inbox
busdev@alkermes.com
-
Unclassified inbox
christy.burchett@alkermes.com
-
Unclassified inbox
brian.blood@alkermes.com
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 27, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
Biobest
Biobest is develops and supplies natural crop care systems.
Specialized In: AgTech, Biotechnology, SaaS
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Jan 4, 2024
Founded Date: 1987
Company Type: For Profit
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@biobestgroup.com (75.0%)
-
Jean-marc Vandoorne
CEO
j****************e@biobestgroup.com
-
Bouchra Zargue
Supply Chain Manager - BIOBEST MAROC / BIOBETTER MAROC
b*****a@biobestgroup.com
-
Roland De Jonghe
Founder
r****d@biobestgroup.com
-
Peter Vanleent
p************t@biobestgroup.com
-
Peter Vanmeijel
p*************l@biobestgroup.com
-
Jeffrey Vandenakker
j*****************r@biobestgroup.com
-
General Inquiries
info@biobest-usa.com
-
Unclassified inbox
mark.wilde@biobestgroup.com
-
Unclassified inbox
salesuk@biobestgroup.com
Ipsen
Ipsen is a global specialty-driven biopharmaceuticShow more...al company focused on innovation and specialty care.
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1929
Number of Exits: 5
Company Type: For Profit
Stock Symbol: EPA:IPN
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@ipsen.com (100.0%)
-
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
s**************i@ipsen.com
-
Susan Tinney
s**********y@ipsen.com
-
Karen Hummel
Executive Director, National Health Systems, Medical Affairs
k**********l@ipsen.com
-
Helen Hsu
h*******u@ipsen.com
-
Katarzyna Wegner
k**************r@ipsen.com
-
Charitable Contributionsna
c************************a@ipsen.com
-
Unclassified inbox
Clinical.trials@ipsen.com
-
Unclassified inbox
corporate.communications@ipsen.com
-
Unclassified inbox
qualitycomplaints.russia.cis@ipsen.com
-
Unclassified inbox
ipsenepe@ipsen.com
-
Unclassified inbox
medical.information.russia.cis@ipsen.com
-
Unclassified inbox
medinfo.uk-ie@ipsen.com
-
Unclassified inbox
contact.web@ipsen.com
-
Unclassified inbox
pierre-et.chabrier@ipsen.com
-
Unclassified inbox
yves.christen@ipsen.com
-
Unclassified inbox
ipsennadigital@ipsen.com
Shionogi
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@shionogi.com (60.0%)
-
Donald Pirkl
Supplier Manager
d****l@shionogi.com
-
Calvin Smith
Key Account Manager
c****h@shionogi.com
-
Fabio De Gregorio
f*********o@shionogi.com
-
Sol Yates
s****s@shionogi.com
-
Laura Littleton
l*************n@shionogi.com
-
Danielle Lewis
d************s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp
-
Unclassified inbox
aaralihalli@shionogi.com
-
Unclassified inbox
corporatecommunications@shionogi.com
BridgeBio
BridgeBio focuses on the development and commerciaShow more...lization of precision medicines for various genetic diseases and cancers.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 2015
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:BBIO
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@bridgebio.com (66.7%)
-
Neil Kumar
Co-Founder & CEO
n********r@bridgebio.com
-
Neil Kumar
Co-Founder & CEO
n****r@bridgebio.com
-
Thomas Parker
Scientist II - MSAT Lead
t*****r@bridgebio.com
-
Jennifer Hodge
j****e@bridgebio.com
-
Brian Stephenson
b*********n@bridgebio.com
-
Academic Research
a***************h@bridgebio.com
-
General Inquiries
info@bridgebio.com
-
Customer Service
support@bridgebio.com
-
Management Department
manager@bridgebio.com
-
General Inquiries
contact@bridgebio.com
-
Sales Department
sales@bridgebio.com
-
Unclassified inbox
mp@bridgebio.com
-
Unclassified inbox
mh@bridgebio.com
-
Unclassified inbox
vb@bridgebio.com
Cullinan Oncology
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
12 Emails
0 Phones
Main email format: ssmith@cullinanoncology.com (100.0%)
-
Corinne Savill
Chief Business Officer
c*****l@cullinanoncology.com
-
Nadim Ahmed
President and CEO
n****d@cullinanoncology.com
-
Jennifer Michaelson
Chief Development Officer
j*********n@cullinanoncology.com
-
Leslie Mariani
Vice President, Finance and Operations
l******i@cullinanoncology.com
-
Jeffrey Trigilio
Chief Financial Officer
j*******o@cullinanoncology.com
-
Sal Firicano
VP and Head of Information Technology
s*******o@cullinanoncology.com
-
General Inquiries
info@cullinoncology.com
-
General Inquiries
contact@cullinanoncology.com
-
Unclassified inbox
klagueerre@cullinanoncology.com
-
Unclassified inbox
u003erhickey@cullinanoncology.com
-
Unclassified inbox
privacy@cullinanoncology.com
-
Unclassified inbox
filn@cullinanoncology.com
Evotec
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@evotec.com (83.3%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
Alessandro Orsetti
a****************i@evotec.com
-
Alex Jakober
Sr Systems Engineer
a**********r@evotec.com
-
Christopher W.
IT Group Leader Site Services
c***********w@evotec.com
-
Patrice Douillard
p***************d@evotec.com
-
Magnus Schroeder
m**************r@evotec.com
-
General Inquiries
info@evotec.com
-
Unclassified inbox
zoe.collins@evotec.com
-
Unclassified inbox
heinz.vonderkammer@evotec.com
-
Unclassified inbox
panhunter@evotec.com
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the developmeShow more...nt of various products for the treatment of rare and ultra-rare diseases.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 26, 2024
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@ultragenyx.com (83.3%)
-
John Klock
Founder
j**n@ultragenyx.com
-
Jung Cho
Associate Director of Validation
j**o@ultragenyx.com
-
Akhilesh Bhambhani
Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops
a********i@ultragenyx.com
-
Marisa Capponi
Associate Director
m******i@ultragenyx.com
-
Benjamin Ehrhart
Vice President, Assistant General Counsel
b******t@ultragenyx.com
-
Xiaohui Lu
Senior Research Scientist
x*u@ultragenyx.com
-
General Inquiries
info@ultragenyx.com
-
Unclassified inbox
trialrecruitment@ultragenyx.com
-
Unclassified inbox
MCorley@ultragenyx.com
-
Investor Relations
higair@ultragenyx.com
-
Media Relations
blakemedia@ultragenyx.com
-
Unclassified inbox
ekakkis@ultragenyx.com
-
Unclassified inbox
gcapiaux@ultragenyx.com
-
Unclassified inbox
mwhetstone@ultragenyx.com
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 11
Company Type: For Profit
Stock Symbol: HKG:2196
Operating Status: Active
Investor Type: Venture Capital
17 Emails
0 Phones
Main email format: smiths@fosunpharma.com (83.3%)
-
Qiyu Chen
Executive Director , Chairman of the Board
c***q@fosunpharma.com
-
Aimin Hui
Executive Presendent of Fosun Pharma; President of Global R&D, Chief Medical Officer
h**a@fosunpharma.com
-
Lijun Wu
CSO of Fosun Pharma / Founder and Head of FUSION Bioventure
w*l@fosunpharma.com
-
Alex Zhu
Executive Director
z**a@fosunpharma.com
-
Zhu Xi
z*u@fosunpharma.com
-
Mike Xu
Co-President
x*m@fosunpharma.com
-
Investor Relations
ir@fosunpharma.com
-
Unclassified inbox
info.usa@fosunpharma.com
-
Unclassified inbox
fosunpharma@wsfg.hk
-
Unclassified inbox
int@fosunpharma.com
-
Unclassified inbox
LastF@fosunpharma.com
-
Unclassified inbox
lianzhengdc@fosunpharma.com
-
Unclassified inbox
hueq@fosunpharma.com
-
Unclassified inbox
xut@fosunpharma.com
-
Human Resources Team
adgenvax.hr@fosunpharma.com
-
Unclassified inbox
yangchen2@fosunpharma.com
-
Unclassified inbox
jszhiliang@fosunpharma.com
Flatiron Health
Flatiron Health is a healthcare technology companyShow more... that aims to improve lives by learning from the experience of every cancer patient.
Specialized In: Biotechnology, Cloud Computing, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 1001-5000
Rounds: Series D
Last Investment Activity: May 16, 2024
Founded Date: Jun 2012
Company Type: For Profit
Operating Status: Active
12 Emails
0 Phones
Main email format: ssmith@flatiron.com (100.0%)
-
Jason Harinstein
CFO
j*********n@flatiron.com
-
Dylan Meacham
Staff Software Engineering Tech Lead
d******m@flatiron.com
-
Puneet Singh
Senior Manager, Interfaces
p****h@flatiron.com
-
Ashley Mcintyre
a*******e@flatiron.com
-
Bruce Gottlieb
Chief Operating Officer
b*******b@flatiron.com
-
Niloy Mukherjee
Founding Member- Product Mastermind Network
n********e@flatiron.com
-
General Inquiries
info@flatiron.com
-
Unclassified inbox
crclark@flatiron.com
-
Unclassified inbox
cdeluca@flatiron.com
-
Unclassified inbox
aoconnor@flatiron.com
-
Unclassified inbox
lsutton@flatiron.com
-
Unclassified inbox
u003edataaccess@flatiron.com
Symrise
Symrise is a global supplier of fragrances, flavorShow more...ings, cosmetic active ingredients, raw materials and functional ingredients.
Specialized In: Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 1, 2024
Founded Date: 1874
Company Type: For Profit
Stock Symbol: ETR:SY1
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@symrise.com (100.0%)
-
Cecilia Kim
Product Manager
c*********m@symrise.com
-
Ravi Pillai
Global Product Manager
r*********i@symrise.com
-
Peter Gollmer
p***********r@symrise.com
-
Lisa Elias
l********s@symrise.com
-
Mikael Herault
m************t@symrise.com
-
Meili Huang
m*********g@symrise.com
-
General Inquiries
info@symrise.com
-
Unclassified inbox
patrice.bellon@symrise.com
-
Unclassified inbox
celine.carrasco@symrise.com
-
Unclassified inbox
s@symrise.com
Karl Storz
Karl Storz is endoscopy manufacture industry for hShow more...uman and veterinary medicine as well as for industrial applications.
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Medical Devices
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Aug 26, 2024
Founded Date: 1945
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@karlstorz.com (100.0%)
-
Paul Fraley
p*********y@karlstorz.com
-
Thiago Cabrino
t************o@karlstorz.com
-
David Rangel
d**********l@karlstorz.com
-
Magne Brekke
m**********e@karlstorz.com
-
Jule Efinger
j**********r@karlstorz.com
-
Annabel Geiger
a************r@karlstorz.com
-
General Inquiries
info@karlstorz.com
-
Legal Department
legal@karlstorz.com
-
Unclassified inbox
william.deeb@karlstorz.com
Genentech
Genentech specializes in genetic testing and persoShow more...nalized medicine.
Specialized In: Biotechnology, Manufacturing & Industrial
Acquired by: Roche
Business Type: Delisted
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: Aug 30, 2024
Founded Date: Jan 1, 1976
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NYSE:DNA
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@gene.com (66.7%)
-
Gig Codiga
g**c@gene.com
-
Jessica Russell Colantonio
c****************a@gene.com
-
Kevin Sharp
President/CEO
s*********n@gene.com
-
Lara Collazo
c******1@gene.com
-
Coia Theresa
c**********a@gene.com
-
Patel Himika
p**********a@gene.com
-
Unclassified inbox
doej@gene.com
-
Unclassified inbox
chen.tao@gene.com
-
Unclassified inbox
carlsson.fredric@gene.com
-
Unclassified inbox
otchyj@gene.com
-
Unclassified inbox
epting@gene.com
Fresenius Medical Care
Fresenius Medical Care is a healthcare company thaShow more...t provides dialysis treatment for those with chronic kidney diseases.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Dec 8, 2023
Founded Date: 1912
Number of Exits: 4
Company Type: For Profit
Stock Symbol: FRA:FME
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@freseniusmedicalcare.com (100.0%)
-
Tanya Coleman
Certified Dialysis Technician
t***********n@freseniusmedicalcare.com
-
Scott Sayres
s**********s@freseniusmedicalcare.com
-
Jonathan Katseanes
j****************s@freseniusmedicalcare.com
-
Steffen Patzak
Senior Vice President
s************k@freseniusmedicalcare.com
-
Gregg Miller
Senior Vice President Operations
g**********r@freseniusmedicalcare.com
-
Unclassified inbox
marketing.international@fmc-ag.com
-
Unclassified inbox
orhan.tore@freseniusmedicalcare.com
-
Unclassified inbox
alexander.witte@freseniusmedicalcare.com
-
Unclassified inbox
john_doe@freseniusmedicalcare.com
Debiopharm Group
Debiopharm Group is a biopharmaceutical developmenShow more...t specialist that in-licenses promising biologics and small molecule drug.
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Pharmaceuticals
Business Type: Private
Employees: 501-1000
Rounds: Grant
Last Investment Activity: Sep 28, 2023
Founded Date: 1979
Number of Exits: 6
Company Type: For Profit
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@debiopharm.com (100.0%)
-
Patrick Garrouste
p***************e@debiopharm.com
-
Valerie Blasco
v************o@debiopharm.com
-
Claire Laprun
c***********n@debiopharm.com
-
U003edawn Bonine
u**************e@debiopharm.com
-
David Cameron
d***********n@debiopharm.com
-
Unclassified inbox
communication@debiopharm.com
-
Unclassified inbox
mwagner@debiopharm.com
-
Unclassified inbox
mmurone@debiopharm.com
-
Unclassified inbox
mbarbier@debiopharm.com
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Kerry Zampa
Head, Global Learning & Organization Development
k****a@theravance.com
-
Venkat Vutukuri
BI Analytics Lead Architect
v*******i@theravance.com
-
Punam Shaida
p*****a@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com
-
Unclassified inbox
rwinningham@theravance.com
-
Unclassified inbox
wmartin@theravance.com
-
Unclassified inbox
ibdstudies@theravance.com
-
Unclassified inbox
amiller@theravance.com
-
Unclassified inbox
tguerin@theravance.com
MorphoSys
MorphoSys is a biotechnology company focused on thShow more...e research and development of fully human antibodies.
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 22, 2024
Founded Date: 1992
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:MOR
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@morphosys.com (75.0%)
-
Gerald Möller
Chairman & Supervisory Board
gm@morphosys.com
-
Delphine El Mehdi
Director, Global Medical Affairs
d************i@morphosys.com
-
20kaitlyn Nealy
2*************y@morphosys.com
-
Greg Romano
g*********o@morphosys.com
-
Nthomas Biegi
n***********i@morphosys.com
-
General Inquiries
info@morphosys.com
-
Unclassified inbox
info.us@morphosys.com
-
Unclassified inbox
weidmann@morphosys.com
-
Unclassified inbox
urlinger@morphosys.com
Zai Lab
Zai Lab brings transformative medicines for cancerShow more..., autoimmune, and infectious diseases to patients in China and around the world.
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 6, 2024
Founded Date: 2014
Company Type: For Profit
Stock Symbol: NASDAQ:ZLAB
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@zailaboratory.com (100.0%)
-
Peter Huang
Chief Scientific Officer
p*********g@zailaboratory.com
-
Karl Hsu
Senior Vice President, Clinical Research and Early Development
k******u@zailaboratory.com
-
6943ronald Aldridge
6*****************e@zailaboratory.com
-
5011danielle Halstrom
5*******************m@zailaboratory.com
-
6943lina Zhang
6************g@zailaboratory.com
-
General Inquiries
info@zailaboratory.com
-
Admin Team
admin@zailaboratory.com
-
Customer Service
support@zailaboratory.com
-
Legal Department
legal@zailaboratory.com
-
Unclassified inbox
bd@zailaboratory.com
-
Human Resources Team
hr@zailaboratory.com
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.